data_1zlc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1zlc _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.737 0.303 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -86.33 -45.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.779 2.32 . . . . 0.0 112.365 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.76 -8.85 23.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.09 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.07 -28.64 35.2 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.556 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -68.29 -27.3 66.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.421 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -99.85 118.0 62.51 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.416 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.29 -9.92 16.79 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.469 2.113 . . . . 0.0 113.022 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.5 t -78.76 -55.87 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.272 0.558 . . . . 0.0 109.813 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 t -63.24 -36.63 84.28 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.432 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.9 t -44.72 -37.01 3.43 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.881 0.372 . . . . 0.0 111.731 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.0 t -63.14 -52.42 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.337 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.75 -0.47 34.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.505 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -131.98 61.6 58.91 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 120.864 0.364 . . . . 0.0 111.036 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -89.11 30.33 0.42 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.912 2.408 . . . . 0.0 112.668 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -111.3 -21.13 12.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.324 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.1 pp -110.86 -28.1 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.788 0.328 . . . . 0.0 111.201 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.4 m . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.916 0.389 . . . . 0.0 110.937 179.922 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.71 0.29 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -88.27 -45.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.858 2.372 . . . . 0.0 112.447 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.482 ' O ' HG21 ' A' ' 11' ' ' THR . 0.4 OUTLIER -56.46 -17.87 9.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.8 178.579 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.434 ' HA ' HG22 ' A' ' 11' ' ' THR . 36.2 t -68.58 -24.58 64.62 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.63 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 97.3 p -69.77 -29.48 66.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.772 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.454 ' O ' ' CG2' ' A' ' 11' ' ' THR . 3.1 m-80 -99.95 105.02 32.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.713 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.517 ' HA ' HG23 ' A' ' 11' ' ' THR . 17.9 Cg_endo -59.57 1.34 0.4 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.854 2.37 . . . . 0.0 113.873 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.7 t -80.48 -56.51 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.128 0.49 . . . . 0.0 110.249 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.6 p -79.88 -28.85 39.89 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.423 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.517 HG23 ' HA ' ' A' ' 8' ' ' PRO . 65.2 p -44.59 -32.87 1.58 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.672 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.4 t -54.68 -49.5 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 121.027 0.441 . . . . 0.0 111.259 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -76.95 -4.42 43.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.414 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.07 65.74 74.7 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.835 0.35 . . . . 0.0 111.021 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -89.14 22.85 0.78 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.868 2.379 . . . . 0.0 112.853 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -99.8 -20.56 16.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 0.0 110.846 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.456 ' N ' ' CD1' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -118.77 -39.37 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 121.062 0.458 . . . . 0.0 110.729 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.403 ' N ' HG12 ' A' ' 17' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.944 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.708 0.29 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -85.94 -44.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.779 2.32 . . . . 0.0 112.345 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.424 ' O ' HG21 ' A' ' 11' ' ' THR . 1.3 m -68.29 -6.86 26.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.031 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 51.6 t -84.54 -25.38 28.8 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.502 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.5 m -68.55 -31.25 70.33 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.025 0.44 . . . . 0.0 110.296 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -100.44 115.86 64.97 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.462 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.473 ' HA ' HG23 ' A' ' 11' ' ' THR . 52.3 Cg_exo -54.7 -14.63 7.9 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.591 2.194 . . . . 0.0 113.118 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t -76.48 -56.48 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.285 0.564 . . . . 0.0 109.733 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.06 -33.06 71.44 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.936 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.473 HG23 ' HA ' ' A' ' 8' ' ' PRO . 54.5 p -44.82 -41.76 7.3 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.545 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.2 t -53.88 -52.1 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.251 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 20.1 m80 -66.23 -14.02 61.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.209 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.58 73.37 22.51 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-O 120.779 0.324 . . . . 0.0 111.037 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -90.17 28.43 0.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.907 2.405 . . . . 0.0 112.726 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -99.8 -22.59 15.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.982 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.482 HG22 HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.13 -40.19 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.03 0.443 . . . . 0.0 110.751 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.406 ' N ' HG12 ' A' ' 17' ' ' ILE . 26.8 p . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.824 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.735 0.302 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -87.61 -44.41 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.924 2.416 . . . . 0.0 112.371 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.32 -13.0 15.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.018 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -74.56 -27.79 60.66 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.529 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.82 -24.91 64.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.551 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -99.87 119.13 60.45 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.493 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.84 -12.42 22.0 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.457 2.105 . . . . 0.0 113.003 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 36.2 t -77.37 -53.38 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.23 0.538 . . . . 0.0 109.993 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.97 -37.14 86.31 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.489 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 t -44.8 -35.41 2.73 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.3 t -59.86 -48.74 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 121.051 0.453 . . . . 0.0 111.298 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -89.6 15.58 9.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.375 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.44 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 2.0 m-80 -140.04 58.29 10.8 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.754 0.311 . . . . 0.0 110.935 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.44 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 68.9 Cg_endo -89.27 24.55 0.66 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.799 2.333 . . . . 0.0 112.843 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -99.74 -21.91 15.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.864 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.437 ' N ' ' CD1' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -117.4 -39.6 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.706 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.408 ' N ' HG12 ' A' ' 17' ' ' ILE . 2.1 m . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.099 0 CA-C-O 120.731 0.301 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -87.81 -44.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.88 2.387 . . . . 0.0 112.324 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.5 m -63.89 -10.11 19.01 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.213 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.22 -30.78 43.42 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.671 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.7 t -68.14 -28.29 67.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.549 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -99.86 127.69 33.06 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.414 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.82 -5.8 17.82 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.31 2.007 . . . . 0.0 112.81 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.8 t -82.09 -57.44 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.298 0.57 . . . . 0.0 109.539 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 t -63.82 -35.5 80.81 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.54 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.3 t -44.8 -39.07 4.97 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.94 0.4 . . . . 0.0 111.638 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 t -60.63 -52.1 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.382 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -79.34 0.52 28.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.469 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.408 ' HB3' ' CD1' ' A' ' 17' ' ' ILE . 2.6 m-80 -127.7 67.27 72.54 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.786 0.327 . . . . 0.0 110.934 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -89.43 19.18 1.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.804 2.336 . . . . 0.0 112.654 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -99.99 -28.94 12.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.131 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 14' ' ' ASN . 1.1 pp -110.83 -29.13 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.106 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.856 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.748 0.309 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -86.78 -44.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.82 2.347 . . . . 0.0 112.392 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -67.37 -7.51 25.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.196 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -82.07 -35.6 28.51 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.385 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.7 t -70.06 -23.4 63.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.651 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.81 114.02 65.42 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.446 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.27 -12.48 20.14 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.48 2.12 . . . . 0.0 112.989 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.82 -55.13 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.3 0.571 . . . . 0.0 109.763 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.37 -36.75 84.95 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.508 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 t -44.87 -36.72 3.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.96 0.409 . . . . 0.0 111.627 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -61.83 -50.91 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.396 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -82.6 4.86 22.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.457 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.402 ' O ' HD13 ' A' ' 17' ' ' ILE . 1.2 m-80 -129.54 68.17 80.01 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.837 0.351 . . . . 0.0 110.906 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -90.06 19.93 1.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.874 2.383 . . . . 0.0 112.707 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -99.88 -30.38 12.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.402 HD13 ' O ' ' A' ' 14' ' ' ASN . 1.2 pp -111.47 -29.67 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.04 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.842 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.698 0.285 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -88.06 -45.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.855 2.37 . . . . 0.0 112.584 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.49 ' O ' HG22 ' A' ' 11' ' ' THR . 1.1 m -63.75 -9.99 17.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.318 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.9 t -82.66 -25.68 32.86 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-O 120.831 0.348 . . . . 0.0 110.551 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.0 m -67.55 -31.34 71.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.028 0.442 . . . . 0.0 110.108 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.423 ' O ' ' CG2' ' A' ' 11' ' ' THR . 1.2 t-20 -99.94 117.26 63.7 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.231 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.449 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 19.6 Cg_endo -58.38 -11.47 11.0 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.54 2.16 . . . . 0.0 113.044 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.75 -56.09 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.262 0.553 . . . . 0.0 109.628 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -69.44 -36.4 76.61 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.899 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.49 HG22 ' O ' ' A' ' 4' ' ' CYS . 80.4 p -44.71 -37.29 3.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.563 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.4 t -58.11 -49.26 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.351 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -80.32 2.79 23.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.616 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -131.31 60.52 53.25 Favored Pre-proline 0 CA--C 1.529 0.164 0 CA-C-O 120.886 0.374 . . . . 0.0 110.961 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -87.89 29.63 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.912 2.408 . . . . 0.0 112.86 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.91 -23.11 15.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.322 . . . . 0.0 110.939 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.439 ' N ' ' CD1' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -117.1 -39.92 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.016 0.436 . . . . 0.0 110.727 179.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.411 ' N ' HG12 ' A' ' 17' ' ' ILE . 9.7 m . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.701 0.286 . . . . 0.0 110.82 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -87.25 -44.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.809 2.339 . . . . 0.0 112.33 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.424 ' O ' HG22 ' A' ' 11' ' ' THR . 0.5 OUTLIER -61.65 -12.86 17.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.943 178.699 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 m -76.58 -23.94 53.52 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.659 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.9 t -67.34 -29.86 69.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.005 0.431 . . . . 0.0 110.331 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.86 111.8 64.54 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.468 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 50.9 Cg_exo -54.17 -14.52 6.47 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.552 2.168 . . . . 0.0 113.111 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.1 t -73.72 -55.62 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-O 121.336 0.589 . . . . 0.0 109.496 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.8 t -67.24 -40.85 86.36 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.457 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 8' ' ' PRO . 47.3 p -44.93 -41.45 7.24 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.597 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 t -52.83 -49.67 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.455 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.22 16.05 7.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.5 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.44 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 4.1 m-80 -137.27 58.13 16.65 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.767 0.318 . . . . 0.0 110.985 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.44 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 67.9 Cg_endo -89.43 28.27 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.838 2.358 . . . . 0.0 112.812 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.81 -22.82 15.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.874 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.456 HG23 HD11 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.94 -39.99 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-O 121.011 0.434 . . . . 0.0 110.707 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.407 ' N ' HG12 ' A' ' 17' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.832 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.527 0.093 0 CA-C-O 120.652 0.263 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -85.67 -46.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.703 2.269 . . . . 0.0 112.332 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.568 ' O ' ' HB3' ' A' ' 10' ' ' CYS . 1.1 m -65.28 -9.45 24.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.912 178.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.2 t -84.11 -28.07 27.76 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.839 0.352 . . . . 0.0 110.715 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -73.37 -28.13 61.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.962 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -99.85 119.41 59.76 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.636 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -55.77 -26.18 55.39 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.389 2.059 . . . . 0.0 112.604 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 10' ' ' CYS . 9.0 p -68.94 -48.23 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 121.587 0.708 . . . . 0.0 109.925 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.568 ' HB3' ' O ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER -61.26 -48.04 83.25 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.436 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.441 HG23 ' N ' ' A' ' 12' ' ' VAL . 4.0 t -44.47 -32.13 1.3 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.859 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.441 ' N ' HG23 ' A' ' 11' ' ' THR . 4.5 t -62.87 -52.51 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 120.95 0.405 . . . . 0.0 111.395 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -94.31 13.68 22.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.431 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.421 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 1.1 m-80 -140.13 58.04 10.19 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.799 0.333 . . . . 0.0 111.055 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 67.3 Cg_endo -88.23 22.27 0.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.743 2.296 . . . . 0.0 112.94 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -99.74 -21.3 15.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.802 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.471 HG22 HD13 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -117.95 -39.45 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.675 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 t . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.89 -179.977 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.695 0.283 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -86.74 -45.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.837 2.358 . . . . 0.0 112.408 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.1 m -64.45 -9.81 20.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.1 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 57.7 m -78.6 -30.4 46.59 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.433 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -68.08 -26.63 65.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.413 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -99.88 115.46 65.54 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.386 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.32 -11.67 17.23 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.394 2.063 . . . . 0.0 113.02 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.4 t -77.68 -55.26 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.244 0.545 . . . . 0.0 109.682 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.19 -38.98 93.3 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.39 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 t -44.95 -36.79 3.55 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.873 0.368 . . . . 0.0 111.528 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.7 t -61.62 -49.87 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.34 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -87.35 11.24 14.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.499 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.445 ' O ' HD11 ' A' ' 17' ' ' ILE . 1.6 m-80 -132.36 65.4 74.79 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-O 120.861 0.362 . . . . 0.0 110.953 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -90.87 20.48 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.861 2.374 . . . . 0.0 112.592 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -101.03 -28.18 12.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.188 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.445 HD11 ' O ' ' A' ' 14' ' ' ASN . 1.1 pp -110.21 -29.52 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.121 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 20.9 p . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 110.979 179.819 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.755 0.312 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -87.77 -44.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.868 2.379 . . . . 0.0 112.298 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.1 t -62.51 -11.36 15.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.127 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.91 -27.27 28.7 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.613 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.2 m -72.8 -22.64 60.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -99.83 107.34 45.87 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.698 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.87 -21.68 27.09 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.412 2.075 . . . . 0.0 112.543 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.8 t -74.96 -52.18 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-O 121.452 0.644 . . . . 0.0 109.389 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.9 t -63.44 -41.57 98.67 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.282 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.6 t -45.35 -36.58 4.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.849 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 t -58.82 -55.43 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.375 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -66.53 -15.4 63.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.214 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.64 76.5 46.65 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.208 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -91.16 26.93 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.964 2.443 . . . . 0.0 112.624 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -106.34 -27.78 10.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.242 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.91 -28.0 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.196 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.867 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.733 0.301 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -86.5 -44.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.793 2.328 . . . . 0.0 112.319 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -66.1 -8.81 25.88 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.143 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.92 -24.82 32.9 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.598 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.61 -31.57 71.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.983 0.421 . . . . 0.0 110.26 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -99.97 134.91 20.6 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.379 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.63 -1.92 11.95 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.341 2.027 . . . . 0.0 112.914 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t -84.78 -58.99 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.222 0.534 . . . . 0.0 109.693 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -61.51 -30.83 70.87 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.496 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.6 t -44.75 -39.19 4.99 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.855 0.359 . . . . 0.0 111.743 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 t -59.8 -50.61 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.188 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.6 -3.19 39.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.46 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.401 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -131.94 59.49 44.88 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-O 120.82 0.343 . . . . 0.0 111.08 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.401 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 65.7 Cg_endo -88.65 27.91 0.5 Allowed 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.817 2.344 . . . . 0.0 112.812 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -99.84 -23.11 15.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 110.878 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.46 HD12 HG22 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.71 -39.83 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.696 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.411 ' N ' HG12 ' A' ' 17' ' ' ILE . 12.4 m . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.889 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.681 0.277 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -86.95 -46.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.818 2.345 . . . . 0.0 112.483 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.556 ' O ' ' HB3' ' A' ' 10' ' ' CYS . 1.2 m -64.12 -9.82 18.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.12 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.1 m -83.26 -25.72 31.38 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.791 0.329 . . . . 0.0 110.838 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -31.03 66.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.82 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -99.87 138.6 20.38 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.694 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.97 -22.77 22.68 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.359 2.039 . . . . 0.0 112.476 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.2 t -73.17 -50.71 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.556 ' HB3' ' O ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -57.29 -47.21 82.07 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.334 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.441 HG22 ' N ' ' A' ' 12' ' ' VAL . 4.9 t -44.68 -33.71 1.94 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.83 -178.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.441 ' N ' HG22 ' A' ' 11' ' ' THR . 2.9 t -66.96 -55.95 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.135 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -71.25 -9.84 58.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.251 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.408 ' O ' HD12 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -124.58 71.7 58.7 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-O 120.812 0.339 . . . . 0.0 111.037 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -90.98 18.78 1.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.84 2.36 . . . . 0.0 112.566 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -99.98 -28.33 13.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.199 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.408 HD12 ' O ' ' A' ' 14' ' ' ASN . 1.2 pp -110.32 -29.34 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.092 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.854 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.623 0.249 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -86.1 -46.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.662 2.241 . . . . 0.0 112.556 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.2 m -67.52 -7.27 24.53 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.194 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.9 t -85.27 -28.91 25.01 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.764 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.4 m -69.0 -30.83 69.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.531 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -99.94 133.23 21.79 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.47 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.52 -1.78 11.76 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.358 2.039 . . . . 0.0 112.926 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t -84.18 -58.57 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 121.264 0.554 . . . . 0.0 109.671 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 t -64.29 -33.16 75.18 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.444 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.5 t -44.68 -39.94 5.52 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.961 0.41 . . . . 0.0 111.728 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 t -60.26 -53.37 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.511 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -84.68 5.59 27.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.698 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.469 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -135.68 54.61 10.62 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.737 0.303 . . . . 0.0 111.181 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.469 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 61.1 Cg_endo -89.31 21.46 0.94 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.844 2.363 . . . . 0.0 112.74 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -107.49 -9.16 16.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.699 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.1 pp -112.33 -28.89 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.771 0.319 . . . . 0.0 111.216 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.876 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.527 0.09 0 CA-C-O 120.721 0.296 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -87.01 -44.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.866 2.377 . . . . 0.0 112.379 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -66.84 -7.74 23.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.272 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.1 t -84.96 -26.21 27.31 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.636 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.9 -31.5 70.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.372 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -99.89 134.94 20.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.433 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.01 -1.46 11.44 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.321 2.014 . . . . 0.0 112.869 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.5 t -84.91 -59.03 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 121.248 0.547 . . . . 0.0 109.719 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -62.99 -30.29 71.48 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.534 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.6 t -44.84 -39.79 5.64 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.825 0.345 . . . . 0.0 111.759 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 t -57.67 -50.45 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.279 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -78.51 -3.26 42.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.347 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.18 60.62 52.34 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-O 120.8 0.333 . . . . 0.0 110.965 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -87.89 38.58 0.5 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.853 2.369 . . . . 0.0 112.646 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -116.28 -18.06 10.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.404 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.86 -27.55 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.729 0.299 . . . . 0.0 111.191 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 29.8 p . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.895 0.378 . . . . 0.0 110.912 179.949 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.404 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.724 0.297 . . . . 0.0 110.866 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 2' ' ' ASP . 87.8 Cg_endo -86.41 -45.43 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.824 2.35 . . . . 0.0 112.371 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.15 -10.19 21.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.07 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 52.3 t -79.21 -27.17 42.51 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.579 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.97 -28.27 67.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.412 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -99.82 130.39 26.57 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.452 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.54 -13.03 32.34 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.367 2.045 . . . . 0.0 112.811 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.475 ' CG1' ' N ' ' A' ' 10' ' ' CYS . 9.8 p -76.54 -50.13 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 121.293 0.568 . . . . 0.0 110.887 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.475 ' N ' ' CG1' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -69.63 -34.75 74.49 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.627 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 t -44.64 -34.61 2.26 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.805 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 t -60.52 -52.09 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.301 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.3 -5.15 57.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.399 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.69 62.06 60.35 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 120.831 0.348 . . . . 0.0 110.866 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -90.33 21.0 0.92 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.82 2.347 . . . . 0.0 112.879 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.409 ' CG ' HD13 ' A' ' 17' ' ' ILE . 10.9 pt20 -99.85 -19.33 16.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.009 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.42 ' N ' ' CD1' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.18 -39.81 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 121.032 0.444 . . . . 0.0 110.608 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.415 ' N ' HG12 ' A' ' 17' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.413 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.981 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.688 0.28 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -88.08 -45.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.826 2.351 . . . . 0.0 112.549 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.88 -10.62 13.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.253 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -30.51 46.2 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.89 0.376 . . . . 0.0 110.573 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 t -70.83 -23.29 62.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.812 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -99.84 116.47 64.69 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.482 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.76 -12.61 22.46 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.456 2.104 . . . . 0.0 112.954 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.48 -54.67 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 121.305 0.574 . . . . 0.0 109.765 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.74 -37.87 89.07 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.494 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 t -44.87 -37.05 3.62 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.837 0.351 . . . . 0.0 111.752 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.0 t -59.24 -50.37 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.339 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -95.55 21.31 8.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.357 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.474 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 3.0 m-80 -136.63 55.73 11.74 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.707 0.289 . . . . 0.0 111.153 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.474 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 64.1 Cg_endo -90.16 20.32 1.04 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.8 2.333 . . . . 0.0 112.787 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -99.83 -20.13 16.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.9 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.445 ' N ' ' CD1' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.62 -39.52 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.038 0.447 . . . . 0.0 110.611 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.5 m . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.863 -179.965 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.69 0.281 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -86.55 -45.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.809 2.339 . . . . 0.0 112.333 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.69 -10.9 21.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.088 178.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.9 t -80.54 -23.65 39.85 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.663 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.8 t -69.31 -28.78 66.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.572 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -99.84 135.86 20.37 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.495 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.99 -3.02 13.31 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.328 2.019 . . . . 0.0 112.902 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.7 t -83.11 -57.73 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-O 121.349 0.595 . . . . 0.0 109.552 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.86 -36.88 82.54 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.346 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.1 t -44.81 -40.1 5.86 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.926 0.393 . . . . 0.0 111.683 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.9 t -60.06 -52.71 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.364 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -80.07 1.08 29.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.485 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.404 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -133.83 60.01 42.94 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.809 0.337 . . . . 0.0 111.036 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.404 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 69.3 Cg_endo -89.51 33.53 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.888 2.392 . . . . 0.0 112.609 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.63 -19.96 11.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.384 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 pp -110.53 -29.23 2.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.752 0.311 . . . . 0.0 111.057 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.4 m . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.922 179.949 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.726 0.298 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -86.42 -45.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.785 2.323 . . . . 0.0 112.304 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.01 -10.42 21.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.987 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 38.0 t -77.37 -29.4 53.28 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.51 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.8 t -68.26 -26.57 65.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.539 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -99.84 116.63 64.56 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.491 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.66 -11.56 17.83 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.452 2.102 . . . . 0.0 113.005 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.2 t -78.72 -55.07 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.278 0.561 . . . . 0.0 109.878 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.94 -34.91 78.47 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.427 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 t -44.77 -35.72 2.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.906 0.384 . . . . 0.0 111.73 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 t -63.34 -49.54 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.238 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -87.44 10.94 15.9 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.411 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.402 ' O ' HD13 ' A' ' 17' ' ' ILE . 1.4 m-80 -134.09 61.92 53.88 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.777 0.322 . . . . 0.0 110.96 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -89.73 21.18 0.94 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.859 2.373 . . . . 0.0 112.7 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -103.53 -25.46 13.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.209 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.402 HD13 ' O ' ' A' ' 14' ' ' ASN . 1.1 pp -110.92 -29.02 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.16 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.7 m . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.927 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.527 0.07 0 CA-C-O 120.766 0.317 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -85.98 -44.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.689 2.259 . . . . 0.0 112.283 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.0 -7.93 26.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.073 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 46.2 t -81.19 -30.79 34.25 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.539 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.3 m -68.48 -27.81 66.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.416 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -99.92 118.17 62.15 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.502 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.66 -9.49 16.23 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.44 2.093 . . . . 0.0 113.035 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.6 t -80.03 -56.35 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 121.234 0.54 . . . . 0.0 109.892 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -63.55 -31.92 73.22 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.566 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 t -44.78 -35.42 2.72 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.75 0.31 . . . . 0.0 111.634 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.8 t -60.19 -52.12 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.035 0.445 . . . . 0.0 111.096 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -72.64 -9.17 58.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.226 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.19 68.75 77.05 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-O 120.839 0.352 . . . . 0.0 110.99 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -90.7 24.99 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.828 2.352 . . . . 0.0 112.578 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -104.15 -25.7 12.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.323 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 pp -110.23 -29.96 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.815 0.34 . . . . 0.0 111.136 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.5 m . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.983 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.805 0.335 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.99 164.01 63.08 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -86.33 -45.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.779 2.32 . . . . 0.0 112.365 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.76 -8.85 23.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.09 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.07 -28.64 35.2 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.556 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -68.29 -27.3 66.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.421 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -99.85 118.0 62.51 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.416 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.29 -9.92 16.79 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.469 2.113 . . . . 0.0 113.022 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.5 t -78.76 -55.87 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.272 0.558 . . . . 0.0 109.813 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 t -63.24 -36.63 84.28 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.432 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.9 t -44.72 -37.01 3.43 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.881 0.372 . . . . 0.0 111.731 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.0 t -63.14 -52.42 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.337 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.75 -0.47 34.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.505 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -131.98 61.6 58.91 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 120.864 0.364 . . . . 0.0 111.036 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -89.11 30.33 0.42 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.912 2.408 . . . . 0.0 112.668 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -111.3 -21.13 12.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.324 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.1 pp -110.86 -28.1 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.788 0.328 . . . . 0.0 111.201 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.4 m -89.78 -23.19 21.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.916 0.389 . . . . 0.0 110.937 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.359 0 O-C-N 122.043 -0.411 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.894 0.378 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.27 175.41 0.41 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.904 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -88.27 -45.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.858 2.372 . . . . 0.0 112.447 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.482 ' O ' HG21 ' A' ' 11' ' ' THR . 0.4 OUTLIER -56.46 -17.87 9.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.8 178.579 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.434 ' HA ' HG22 ' A' ' 11' ' ' THR . 36.2 t -68.58 -24.58 64.62 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.63 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 97.3 p -69.77 -29.48 66.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.772 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.454 ' O ' ' CG2' ' A' ' 11' ' ' THR . 3.1 m-80 -99.95 105.02 32.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.713 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.517 ' HA ' HG23 ' A' ' 11' ' ' THR . 17.9 Cg_endo -59.57 1.34 0.4 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.854 2.37 . . . . 0.0 113.873 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.7 t -80.48 -56.51 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.128 0.49 . . . . 0.0 110.249 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.6 p -79.88 -28.85 39.89 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.423 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.517 HG23 ' HA ' ' A' ' 8' ' ' PRO . 65.2 p -44.59 -32.87 1.58 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.672 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.4 t -54.68 -49.5 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 121.027 0.441 . . . . 0.0 111.259 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -76.95 -4.42 43.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.414 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.07 65.74 74.7 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.835 0.35 . . . . 0.0 111.021 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -89.14 22.85 0.78 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.868 2.379 . . . . 0.0 112.853 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -99.8 -20.56 16.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 0.0 110.846 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.456 ' N ' ' CD1' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -118.77 -39.37 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 121.062 0.458 . . . . 0.0 110.729 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.403 ' N ' HG12 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -93.17 37.52 1.04 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.944 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.341 0 O-C-N 122.018 -0.426 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 10.6 mtp180 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.807 0.337 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.25 169.33 1.27 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -85.94 -44.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.779 2.32 . . . . 0.0 112.345 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.424 ' O ' HG21 ' A' ' 11' ' ' THR . 1.3 m -68.29 -6.86 26.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.031 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 51.6 t -84.54 -25.38 28.8 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.502 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.5 m -68.55 -31.25 70.33 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.025 0.44 . . . . 0.0 110.296 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -100.44 115.86 64.97 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.462 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.473 ' HA ' HG23 ' A' ' 11' ' ' THR . 52.3 Cg_exo -54.7 -14.63 7.9 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.591 2.194 . . . . 0.0 113.118 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t -76.48 -56.48 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.285 0.564 . . . . 0.0 109.733 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.06 -33.06 71.44 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.936 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.473 HG23 ' HA ' ' A' ' 8' ' ' PRO . 54.5 p -44.82 -41.76 7.3 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.545 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.2 t -53.88 -52.1 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.251 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 20.1 m80 -66.23 -14.02 61.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.209 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.58 73.37 22.51 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-O 120.779 0.324 . . . . 0.0 111.037 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.513 ' HA ' ' N ' ' A' ' 19' ' ' NH2 . 64.3 Cg_endo -90.17 28.43 0.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.907 2.405 . . . . 0.0 112.726 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -99.8 -22.59 15.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.982 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.482 HG22 HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.13 -40.19 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.03 0.443 . . . . 0.0 110.751 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.406 ' N ' HG12 ' A' ' 17' ' ' ILE . 26.8 p -150.01 40.51 0.8 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.824 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . 0.513 ' N ' ' HA ' ' A' ' 15' ' ' PRO . . . . . . . . 0 C--N 1.328 -0.352 0 O-C-N 122.037 -0.415 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.804 0.335 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.55 175.23 4.83 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -87.61 -44.41 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.924 2.416 . . . . 0.0 112.371 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.32 -13.0 15.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.018 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -74.56 -27.79 60.66 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.529 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.82 -24.91 64.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.551 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -99.87 119.13 60.45 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.493 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.84 -12.42 22.0 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.457 2.105 . . . . 0.0 113.003 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 36.2 t -77.37 -53.38 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.23 0.538 . . . . 0.0 109.993 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.97 -37.14 86.31 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.489 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 t -44.8 -35.41 2.73 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.3 t -59.86 -48.74 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 121.051 0.453 . . . . 0.0 111.298 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -89.6 15.58 9.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.375 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.44 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 2.0 m-80 -140.04 58.29 10.8 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.754 0.311 . . . . 0.0 110.935 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.44 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 68.9 Cg_endo -89.27 24.55 0.66 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.799 2.333 . . . . 0.0 112.843 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -99.74 -21.91 15.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.864 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.437 ' N ' ' CD1' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -117.4 -39.6 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.706 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.408 ' N ' HG12 ' A' ' 17' ' ' ILE . 2.1 m -103.66 143.25 33.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.904 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.376 0 O-C-N 122.07 -0.393 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.86 0.362 . . . . 0.0 111.172 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.37 161.66 13.12 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -87.81 -44.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.88 2.387 . . . . 0.0 112.324 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.5 m -63.89 -10.11 19.01 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.213 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.22 -30.78 43.42 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.671 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.7 t -68.14 -28.29 67.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.549 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -99.86 127.69 33.06 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.414 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.82 -5.8 17.82 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.31 2.007 . . . . 0.0 112.81 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.8 t -82.09 -57.44 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.298 0.57 . . . . 0.0 109.539 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 t -63.82 -35.5 80.81 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.54 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.3 t -44.8 -39.07 4.97 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.94 0.4 . . . . 0.0 111.638 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 t -60.63 -52.1 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.382 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -79.34 0.52 28.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.469 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.408 ' HB3' ' CD1' ' A' ' 17' ' ' ILE . 2.6 m-80 -127.7 67.27 72.54 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.786 0.327 . . . . 0.0 110.934 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -89.43 19.18 1.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.804 2.336 . . . . 0.0 112.654 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -99.99 -28.94 12.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.131 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 14' ' ' ASN . 1.1 pp -110.83 -29.13 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.106 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -98.34 161.77 13.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.856 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.319 0 O-C-N 122.077 -0.389 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.856 0.36 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.99 162.22 73.59 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -86.78 -44.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.82 2.347 . . . . 0.0 112.392 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -67.37 -7.51 25.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.196 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -82.07 -35.6 28.51 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.385 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.7 t -70.06 -23.4 63.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.651 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.81 114.02 65.42 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.446 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.27 -12.48 20.14 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.48 2.12 . . . . 0.0 112.989 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.82 -55.13 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.3 0.571 . . . . 0.0 109.763 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.37 -36.75 84.95 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.508 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 t -44.87 -36.72 3.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.96 0.409 . . . . 0.0 111.627 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -61.83 -50.91 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.396 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -82.6 4.86 22.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.457 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.402 ' O ' HD13 ' A' ' 17' ' ' ILE . 1.2 m-80 -129.54 68.17 80.01 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.837 0.351 . . . . 0.0 110.906 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -90.06 19.93 1.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.874 2.383 . . . . 0.0 112.707 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -99.88 -30.38 12.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.402 HD13 ' O ' ' A' ' 14' ' ' ASN . 1.2 pp -111.47 -29.67 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.04 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.07 -97.39 0.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.842 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.343 0 O-C-N 122.009 -0.432 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 6.2 mtt85 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.808 0.337 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.97 149.73 96.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -88.06 -45.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.855 2.37 . . . . 0.0 112.584 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.49 ' O ' HG22 ' A' ' 11' ' ' THR . 1.1 m -63.75 -9.99 17.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.318 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.9 t -82.66 -25.68 32.86 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-O 120.831 0.348 . . . . 0.0 110.551 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.0 m -67.55 -31.34 71.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.028 0.442 . . . . 0.0 110.108 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.423 ' O ' ' CG2' ' A' ' 11' ' ' THR . 1.2 t-20 -99.94 117.26 63.7 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.231 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.449 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 19.6 Cg_endo -58.38 -11.47 11.0 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.54 2.16 . . . . 0.0 113.044 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.75 -56.09 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.262 0.553 . . . . 0.0 109.628 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -69.44 -36.4 76.61 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.899 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.49 HG22 ' O ' ' A' ' 4' ' ' CYS . 80.4 p -44.71 -37.29 3.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.563 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.4 t -58.11 -49.26 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.351 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -80.32 2.79 23.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.616 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -131.31 60.52 53.25 Favored Pre-proline 0 CA--C 1.529 0.164 0 CA-C-O 120.886 0.374 . . . . 0.0 110.961 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -87.89 29.63 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.912 2.408 . . . . 0.0 112.86 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.91 -23.11 15.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.322 . . . . 0.0 110.939 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.439 ' N ' ' CD1' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -117.1 -39.92 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.016 0.436 . . . . 0.0 110.727 179.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.411 ' N ' HG12 ' A' ' 17' ' ' ILE . 9.7 m -73.23 140.59 47.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.896 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.35 0 O-C-N 122.059 -0.401 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 77.6 mtt-85 . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.802 0.334 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.03 167.96 2.47 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.82 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -87.25 -44.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.809 2.339 . . . . 0.0 112.33 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.424 ' O ' HG22 ' A' ' 11' ' ' THR . 0.5 OUTLIER -61.65 -12.86 17.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.943 178.699 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 m -76.58 -23.94 53.52 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.659 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.9 t -67.34 -29.86 69.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.005 0.431 . . . . 0.0 110.331 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.86 111.8 64.54 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.468 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 50.9 Cg_exo -54.17 -14.52 6.47 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.552 2.168 . . . . 0.0 113.111 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.1 t -73.72 -55.62 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-O 121.336 0.589 . . . . 0.0 109.496 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.8 t -67.24 -40.85 86.36 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.457 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 8' ' ' PRO . 47.3 p -44.93 -41.45 7.24 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.597 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 t -52.83 -49.67 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.455 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.22 16.05 7.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.5 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.44 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 4.1 m-80 -137.27 58.13 16.65 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.767 0.318 . . . . 0.0 110.985 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.44 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 67.9 Cg_endo -89.43 28.27 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.838 2.358 . . . . 0.0 112.812 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.81 -22.82 15.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.874 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.456 HG23 HD11 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.94 -39.99 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-O 121.011 0.434 . . . . 0.0 110.707 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.407 ' N ' HG12 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -72.05 107.6 4.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.832 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.349 0 O-C-N 122.066 -0.396 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.6 mpp_? . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.817 0.342 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.8 166.31 3.61 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.878 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -85.67 -46.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.703 2.269 . . . . 0.0 112.332 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.568 ' O ' ' HB3' ' A' ' 10' ' ' CYS . 1.1 m -65.28 -9.45 24.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.912 178.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.2 t -84.11 -28.07 27.76 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.839 0.352 . . . . 0.0 110.715 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -73.37 -28.13 61.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.962 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -99.85 119.41 59.76 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.636 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -55.77 -26.18 55.39 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.389 2.059 . . . . 0.0 112.604 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 10' ' ' CYS . 9.0 p -68.94 -48.23 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 121.587 0.708 . . . . 0.0 109.925 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.568 ' HB3' ' O ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER -61.26 -48.04 83.25 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.436 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.441 HG23 ' N ' ' A' ' 12' ' ' VAL . 4.0 t -44.47 -32.13 1.3 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.859 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.441 ' N ' HG23 ' A' ' 11' ' ' THR . 4.5 t -62.87 -52.51 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 120.95 0.405 . . . . 0.0 111.395 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -94.31 13.68 22.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.431 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.421 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 1.1 m-80 -140.13 58.04 10.19 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.799 0.333 . . . . 0.0 111.055 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 67.3 Cg_endo -88.23 22.27 0.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.743 2.296 . . . . 0.0 112.94 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -99.74 -21.3 15.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.802 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.471 HG22 HD13 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -117.95 -39.45 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.675 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 t -97.2 -163.67 1.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.89 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.348 0 O-C-N 122.077 -0.389 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.78 0.324 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.82 172.05 1.25 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.845 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -86.74 -45.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.837 2.358 . . . . 0.0 112.408 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.1 m -64.45 -9.81 20.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.1 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 57.7 m -78.6 -30.4 46.59 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.433 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -68.08 -26.63 65.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.413 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -99.88 115.46 65.54 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.386 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.32 -11.67 17.23 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.394 2.063 . . . . 0.0 113.02 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.4 t -77.68 -55.26 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.244 0.545 . . . . 0.0 109.682 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.19 -38.98 93.3 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.39 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 t -44.95 -36.79 3.55 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.873 0.368 . . . . 0.0 111.528 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.7 t -61.62 -49.87 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.34 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -87.35 11.24 14.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.499 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.445 ' O ' HD11 ' A' ' 17' ' ' ILE . 1.6 m-80 -132.36 65.4 74.79 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-O 120.861 0.362 . . . . 0.0 110.953 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -90.87 20.48 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.861 2.374 . . . . 0.0 112.592 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -101.03 -28.18 12.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.188 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.445 HD11 ' O ' ' A' ' 14' ' ' ASN . 1.1 pp -110.21 -29.52 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.121 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' A' ' 19' ' ' NH2 . 20.9 p -164.44 -50.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 110.979 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . 0.424 ' N ' ' SG ' ' A' ' 18' ' ' CYS . . . . . . . . 0 C--N 1.327 -0.379 0 O-C-N 122.083 -0.386 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.766 0.317 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.91 149.38 53.3 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -87.77 -44.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.868 2.379 . . . . 0.0 112.298 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.1 t -62.51 -11.36 15.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.127 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.91 -27.27 28.7 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.613 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.2 m -72.8 -22.64 60.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -99.83 107.34 45.87 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.698 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.87 -21.68 27.09 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.412 2.075 . . . . 0.0 112.543 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.8 t -74.96 -52.18 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-O 121.452 0.644 . . . . 0.0 109.389 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.9 t -63.44 -41.57 98.67 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.282 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.6 t -45.35 -36.58 4.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.849 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 t -58.82 -55.43 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.375 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -66.53 -15.4 63.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.214 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.64 76.5 46.65 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.208 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -91.16 26.93 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.964 2.443 . . . . 0.0 112.624 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -106.34 -27.78 10.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.242 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.91 -28.0 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.196 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -107.11 -77.93 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.867 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.34 0 O-C-N 122.024 -0.422 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.871 0.367 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.85 174.16 0.48 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -86.5 -44.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.793 2.328 . . . . 0.0 112.319 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -66.1 -8.81 25.88 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.143 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.92 -24.82 32.9 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.598 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.61 -31.57 71.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.983 0.421 . . . . 0.0 110.26 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -99.97 134.91 20.6 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.379 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.63 -1.92 11.95 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.341 2.027 . . . . 0.0 112.914 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t -84.78 -58.99 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.222 0.534 . . . . 0.0 109.693 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -61.51 -30.83 70.87 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.496 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.6 t -44.75 -39.19 4.99 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.855 0.359 . . . . 0.0 111.743 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 t -59.8 -50.61 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.188 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.6 -3.19 39.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.46 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.401 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -131.94 59.49 44.88 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-O 120.82 0.343 . . . . 0.0 111.08 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.401 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 65.7 Cg_endo -88.65 27.91 0.5 Allowed 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.817 2.344 . . . . 0.0 112.812 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -99.84 -23.11 15.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 110.878 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.46 HD12 HG22 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.71 -39.83 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.696 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.411 ' N ' HG12 ' A' ' 17' ' ' ILE . 12.4 m -80.87 79.43 7.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.889 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.372 0 O-C-N 122.103 -0.373 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.835 0.35 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -59.89 158.35 25.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -86.95 -46.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.818 2.345 . . . . 0.0 112.483 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.556 ' O ' ' HB3' ' A' ' 10' ' ' CYS . 1.2 m -64.12 -9.82 18.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.12 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.1 m -83.26 -25.72 31.38 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.791 0.329 . . . . 0.0 110.838 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -31.03 66.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.82 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -99.87 138.6 20.38 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.694 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.97 -22.77 22.68 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.359 2.039 . . . . 0.0 112.476 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.2 t -73.17 -50.71 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.556 ' HB3' ' O ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -57.29 -47.21 82.07 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.334 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.441 HG22 ' N ' ' A' ' 12' ' ' VAL . 4.9 t -44.68 -33.71 1.94 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.83 -178.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.441 ' N ' HG22 ' A' ' 11' ' ' THR . 2.9 t -66.96 -55.95 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.135 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -71.25 -9.84 58.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.251 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.408 ' O ' HD12 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -124.58 71.7 58.7 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-O 120.812 0.339 . . . . 0.0 111.037 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -90.98 18.78 1.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.84 2.36 . . . . 0.0 112.566 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -99.98 -28.33 13.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.199 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.408 HD12 ' O ' ' A' ' 14' ' ' ASN . 1.2 pp -110.32 -29.34 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.092 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.63 151.05 24.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.854 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.353 0 O-C-N 122.083 -0.385 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.817 0.341 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -77.84 146.43 72.27 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.857 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -86.1 -46.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.662 2.241 . . . . 0.0 112.556 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.2 m -67.52 -7.27 24.53 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.194 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.9 t -85.27 -28.91 25.01 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.764 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.4 m -69.0 -30.83 69.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.531 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -99.94 133.23 21.79 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.47 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.52 -1.78 11.76 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.358 2.039 . . . . 0.0 112.926 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t -84.18 -58.57 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 121.264 0.554 . . . . 0.0 109.671 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 t -64.29 -33.16 75.18 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.444 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.5 t -44.68 -39.94 5.52 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.961 0.41 . . . . 0.0 111.728 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 t -60.26 -53.37 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.511 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -84.68 5.59 27.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.698 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.469 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -135.68 54.61 10.62 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.737 0.303 . . . . 0.0 111.181 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.469 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 61.1 Cg_endo -89.31 21.46 0.94 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.844 2.363 . . . . 0.0 112.74 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -107.49 -9.16 16.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.699 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.1 pp -112.33 -28.89 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.771 0.319 . . . . 0.0 111.216 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.38 -48.67 1.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.876 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 O-C-N 122.047 -0.408 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.804 0.335 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.01 152.48 92.85 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.941 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -87.01 -44.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.866 2.377 . . . . 0.0 112.379 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -66.84 -7.74 23.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.272 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.1 t -84.96 -26.21 27.31 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.636 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.9 -31.5 70.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.372 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -99.89 134.94 20.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.433 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.01 -1.46 11.44 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.321 2.014 . . . . 0.0 112.869 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.5 t -84.91 -59.03 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 121.248 0.547 . . . . 0.0 109.719 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -62.99 -30.29 71.48 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.534 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.6 t -44.84 -39.79 5.64 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.825 0.345 . . . . 0.0 111.759 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 t -57.67 -50.45 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.279 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -78.51 -3.26 42.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.347 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.18 60.62 52.34 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-O 120.8 0.333 . . . . 0.0 110.965 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -87.89 38.58 0.5 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.853 2.369 . . . . 0.0 112.646 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -116.28 -18.06 10.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.404 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.86 -27.55 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.729 0.299 . . . . 0.0 111.191 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 29.8 p -169.33 14.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.895 0.378 . . . . 0.0 110.912 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.352 0 O-C-N 122.077 -0.389 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.776 0.322 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.404 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.2 OUTLIER -84.92 175.97 4.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 2' ' ' ASP . 87.8 Cg_endo -86.41 -45.43 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.824 2.35 . . . . 0.0 112.371 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.15 -10.19 21.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.07 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 52.3 t -79.21 -27.17 42.51 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.579 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.97 -28.27 67.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.412 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -99.82 130.39 26.57 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.452 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.54 -13.03 32.34 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.367 2.045 . . . . 0.0 112.811 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.475 ' CG1' ' N ' ' A' ' 10' ' ' CYS . 9.8 p -76.54 -50.13 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 121.293 0.568 . . . . 0.0 110.887 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.475 ' N ' ' CG1' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -69.63 -34.75 74.49 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.627 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 t -44.64 -34.61 2.26 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.805 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 t -60.52 -52.09 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.301 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.3 -5.15 57.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.399 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.69 62.06 60.35 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 120.831 0.348 . . . . 0.0 110.866 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -90.33 21.0 0.92 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.82 2.347 . . . . 0.0 112.879 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.409 ' CG ' HD13 ' A' ' 17' ' ' ILE . 10.9 pt20 -99.85 -19.33 16.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.009 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.42 ' N ' ' CD1' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.18 -39.81 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 121.032 0.444 . . . . 0.0 110.608 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.415 ' N ' HG12 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -85.53 -30.98 22.97 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.981 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.343 0 O-C-N 122.04 -0.412 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.6 ptt85 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.866 0.365 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -82.77 162.05 56.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.804 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -88.08 -45.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.826 2.351 . . . . 0.0 112.549 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.88 -10.62 13.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.253 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -30.51 46.2 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.89 0.376 . . . . 0.0 110.573 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 t -70.83 -23.29 62.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.812 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -99.84 116.47 64.69 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.482 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.76 -12.61 22.46 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.456 2.104 . . . . 0.0 112.954 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.48 -54.67 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 121.305 0.574 . . . . 0.0 109.765 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.74 -37.87 89.07 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.494 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 t -44.87 -37.05 3.62 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.837 0.351 . . . . 0.0 111.752 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.0 t -59.24 -50.37 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.339 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -95.55 21.31 8.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.357 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.474 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 3.0 m-80 -136.63 55.73 11.74 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.707 0.289 . . . . 0.0 111.153 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.474 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 64.1 Cg_endo -90.16 20.32 1.04 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.8 2.333 . . . . 0.0 112.787 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -99.83 -20.13 16.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.9 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.445 ' N ' ' CD1' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.62 -39.52 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.038 0.447 . . . . 0.0 110.611 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.5 m -78.12 77.98 4.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.863 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.344 0 O-C-N 122.046 -0.408 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.6 mtp-105 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.831 0.348 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.93 168.04 5.18 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.855 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -86.55 -45.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.809 2.339 . . . . 0.0 112.333 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.69 -10.9 21.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.088 178.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.9 t -80.54 -23.65 39.85 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.663 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.8 t -69.31 -28.78 66.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.572 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -99.84 135.86 20.37 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.495 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.99 -3.02 13.31 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.328 2.019 . . . . 0.0 112.902 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.7 t -83.11 -57.73 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-O 121.349 0.595 . . . . 0.0 109.552 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.86 -36.88 82.54 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.346 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.1 t -44.81 -40.1 5.86 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.926 0.393 . . . . 0.0 111.683 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.9 t -60.06 -52.71 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.364 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -80.07 1.08 29.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.485 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.404 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -133.83 60.01 42.94 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.809 0.337 . . . . 0.0 111.036 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.404 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 69.3 Cg_endo -89.51 33.53 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.888 2.392 . . . . 0.0 112.609 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.63 -19.96 11.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.384 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 pp -110.53 -29.23 2.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.752 0.311 . . . . 0.0 111.057 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.4 m -133.8 105.35 6.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.922 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 O-C-N 122.066 -0.396 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.814 0.34 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.26 171.96 11.1 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.808 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -86.42 -45.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.785 2.323 . . . . 0.0 112.304 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.01 -10.42 21.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.987 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 38.0 t -77.37 -29.4 53.28 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.51 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.8 t -68.26 -26.57 65.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.539 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -99.84 116.63 64.56 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.491 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.66 -11.56 17.83 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.452 2.102 . . . . 0.0 113.005 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.2 t -78.72 -55.07 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.278 0.561 . . . . 0.0 109.878 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.94 -34.91 78.47 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.427 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 t -44.77 -35.72 2.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.906 0.384 . . . . 0.0 111.73 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 t -63.34 -49.54 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.238 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -87.44 10.94 15.9 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.411 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.402 ' O ' HD13 ' A' ' 17' ' ' ILE . 1.4 m-80 -134.09 61.92 53.88 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.777 0.322 . . . . 0.0 110.96 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -89.73 21.18 0.94 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.859 2.373 . . . . 0.0 112.7 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -103.53 -25.46 13.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.209 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.402 HD13 ' O ' ' A' ' 14' ' ' ASN . 1.1 pp -110.92 -29.02 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.16 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.7 m -138.41 -166.38 1.98 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.927 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.357 0 O-C-N 122.079 -0.388 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.828 0.347 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.92 162.81 8.81 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.813 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -85.98 -44.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.689 2.259 . . . . 0.0 112.283 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.0 -7.93 26.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.073 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 46.2 t -81.19 -30.79 34.25 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.539 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.3 m -68.48 -27.81 66.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.416 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -99.92 118.17 62.15 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.502 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.66 -9.49 16.23 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.44 2.093 . . . . 0.0 113.035 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.6 t -80.03 -56.35 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 121.234 0.54 . . . . 0.0 109.892 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -63.55 -31.92 73.22 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.566 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 t -44.78 -35.42 2.72 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.75 0.31 . . . . 0.0 111.634 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.8 t -60.19 -52.12 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.035 0.445 . . . . 0.0 111.096 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -72.64 -9.17 58.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.226 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.19 68.75 77.05 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-O 120.839 0.352 . . . . 0.0 110.99 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -90.7 24.99 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.828 2.352 . . . . 0.0 112.578 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -104.15 -25.7 12.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.323 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 pp -110.23 -29.96 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.815 0.34 . . . . 0.0 111.136 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.5 m -147.08 166.08 27.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.391 0 O-C-N 122.065 -0.397 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.475 ' OD2' HG21 ' A' ' 17' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.737 0.303 . . . . 0.0 110.913 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -86.33 -45.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.779 2.32 . . . . 0.0 112.365 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.76 -8.85 23.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.09 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.07 -28.64 35.2 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.556 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -68.29 -27.3 66.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.421 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -99.85 118.0 62.51 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.416 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.717 ' O ' HG22 ' A' ' 11' ' ' THR . 26.2 Cg_exo -62.29 -9.92 16.79 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.469 2.113 . . . . 0.0 113.022 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.5 t -78.76 -55.87 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.272 0.558 . . . . 0.0 109.813 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 t -63.24 -36.63 84.28 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.432 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.717 HG22 ' O ' ' A' ' 8' ' ' PRO . 3.9 t -44.72 -37.01 3.43 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.881 0.372 . . . . 0.0 111.731 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.0 t -63.14 -52.42 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.337 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.75 -0.47 34.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.505 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.619 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -131.98 61.6 58.91 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 120.864 0.364 . . . . 0.0 111.036 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -89.11 30.33 0.42 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.912 2.408 . . . . 0.0 112.668 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -111.3 -21.13 12.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.324 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.619 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.1 pp -110.86 -28.1 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.788 0.328 . . . . 0.0 111.201 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.458 ' N ' HD12 ' A' ' 17' ' ' ILE . 80.4 m . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.916 0.389 . . . . 0.0 110.937 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.71 0.29 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -88.27 -45.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.858 2.372 . . . . 0.0 112.447 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -56.46 -17.87 9.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.8 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.732 ' HA ' HG22 ' A' ' 11' ' ' THR . 36.2 t -68.58 -24.58 64.62 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.63 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 97.3 p -69.77 -29.48 66.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.772 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.981 ' O ' HG23 ' A' ' 11' ' ' THR . 3.1 m-80 -99.95 105.02 32.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.713 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.501 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 17.9 Cg_endo -59.57 1.34 0.4 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.854 2.37 . . . . 0.0 113.873 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.7 t -80.48 -56.51 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.128 0.49 . . . . 0.0 110.249 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.6 p -79.88 -28.85 39.89 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.423 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.981 HG23 ' O ' ' A' ' 7' ' ' ASN . 65.2 p -44.59 -32.87 1.58 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.672 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.418 ' H ' HG23 ' A' ' 12' ' ' VAL . 9.4 t -54.68 -49.5 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 121.027 0.441 . . . . 0.0 111.259 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -76.95 -4.42 43.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.414 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.619 ' HB3' HD11 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -129.07 65.74 74.7 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.835 0.35 . . . . 0.0 111.021 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -89.14 22.85 0.78 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.868 2.379 . . . . 0.0 112.853 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -99.8 -20.56 16.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 0.0 110.846 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.819 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -118.77 -39.37 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 121.062 0.458 . . . . 0.0 110.729 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.403 ' N ' HG12 ' A' ' 17' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.944 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.708 0.29 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -85.94 -44.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.779 2.32 . . . . 0.0 112.345 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -68.29 -6.86 26.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.031 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.811 ' HA ' HG22 ' A' ' 11' ' ' THR . 51.6 t -84.54 -25.38 28.8 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.502 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.5 m -68.55 -31.25 70.33 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.025 0.44 . . . . 0.0 110.296 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.901 ' O ' HG23 ' A' ' 11' ' ' THR . 16.3 m-80 -100.44 115.86 64.97 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.462 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.515 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 52.3 Cg_exo -54.7 -14.63 7.9 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.591 2.194 . . . . 0.0 113.118 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t -76.48 -56.48 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.285 0.564 . . . . 0.0 109.733 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.06 -33.06 71.44 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.936 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.901 HG23 ' O ' ' A' ' 7' ' ' ASN . 54.5 p -44.82 -41.76 7.3 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.545 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.432 ' H ' HG23 ' A' ' 12' ' ' VAL . 4.2 t -53.88 -52.1 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.251 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 20.1 m80 -66.23 -14.02 61.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.209 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.544 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -120.58 73.37 22.51 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-O 120.779 0.324 . . . . 0.0 111.037 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -90.17 28.43 0.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.907 2.405 . . . . 0.0 112.726 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -99.8 -22.59 15.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.982 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.838 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.13 -40.19 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.03 0.443 . . . . 0.0 110.751 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.407 ' N ' HG12 ' A' ' 17' ' ' ILE . 26.8 p . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.824 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.735 0.302 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -87.61 -44.41 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.924 2.416 . . . . 0.0 112.371 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.32 -13.0 15.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.018 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -74.56 -27.79 60.66 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.529 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.82 -24.91 64.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.551 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -99.87 119.13 60.45 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.493 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.791 ' O ' HG22 ' A' ' 11' ' ' THR . 34.3 Cg_exo -60.84 -12.42 22.0 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.457 2.105 . . . . 0.0 113.003 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 36.2 t -77.37 -53.38 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.23 0.538 . . . . 0.0 109.993 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.97 -37.14 86.31 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.489 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.791 HG22 ' O ' ' A' ' 8' ' ' PRO . 5.5 t -44.8 -35.41 2.73 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.3 t -59.86 -48.74 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 121.051 0.453 . . . . 0.0 111.298 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -89.6 15.58 9.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.375 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.462 ' HB3' HD11 ' A' ' 17' ' ' ILE . 2.0 m-80 -140.04 58.29 10.8 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.754 0.311 . . . . 0.0 110.935 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 68.9 Cg_endo -89.27 24.55 0.66 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.799 2.333 . . . . 0.0 112.843 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -99.74 -21.91 15.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.864 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.818 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -117.4 -39.6 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.706 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.41 ' N ' HG12 ' A' ' 17' ' ' ILE . 2.1 m . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.099 0 CA-C-O 120.731 0.301 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -87.81 -44.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.88 2.387 . . . . 0.0 112.324 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.5 m -63.89 -10.11 19.01 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.213 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.22 -30.78 43.42 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.671 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.7 t -68.14 -28.29 67.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.549 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -99.86 127.69 33.06 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.414 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.604 ' O ' HG22 ' A' ' 11' ' ' THR . 59.0 Cg_endo -71.82 -5.8 17.82 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.31 2.007 . . . . 0.0 112.81 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.8 t -82.09 -57.44 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.298 0.57 . . . . 0.0 109.539 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 t -63.82 -35.5 80.81 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.54 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.604 HG22 ' O ' ' A' ' 8' ' ' PRO . 5.3 t -44.8 -39.07 4.97 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.94 0.4 . . . . 0.0 111.638 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 t -60.63 -52.1 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.382 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -79.34 0.52 28.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.469 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.804 ' HB3' HD11 ' A' ' 17' ' ' ILE . 2.6 m-80 -127.7 67.27 72.54 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.786 0.327 . . . . 0.0 110.934 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -89.43 19.18 1.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.804 2.336 . . . . 0.0 112.654 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -99.99 -28.94 12.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.131 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.804 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.1 pp -110.83 -29.13 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.106 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.562 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.856 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.748 0.309 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -86.78 -44.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.82 2.347 . . . . 0.0 112.392 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -67.37 -7.51 25.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.196 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -82.07 -35.6 28.51 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.385 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.7 t -70.06 -23.4 63.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.651 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.81 114.02 65.42 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.446 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.675 ' O ' HG22 ' A' ' 11' ' ' THR . 38.7 Cg_exo -60.27 -12.48 20.14 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.48 2.12 . . . . 0.0 112.989 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.82 -55.13 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.3 0.571 . . . . 0.0 109.763 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.37 -36.75 84.95 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.508 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 8' ' ' PRO . 2.8 t -44.87 -36.72 3.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.96 0.409 . . . . 0.0 111.627 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -61.83 -50.91 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.396 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -82.6 4.86 22.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.457 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.812 ' HB3' HD11 ' A' ' 17' ' ' ILE . 1.2 m-80 -129.54 68.17 80.01 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.837 0.351 . . . . 0.0 110.906 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -90.06 19.93 1.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.874 2.383 . . . . 0.0 112.707 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -99.88 -30.38 12.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.812 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.2 pp -111.47 -29.67 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.04 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.707 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.842 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.698 0.285 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -88.06 -45.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.855 2.37 . . . . 0.0 112.584 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 10' ' ' CYS . 1.1 m -63.75 -9.99 17.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.318 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.871 ' HA ' HG22 ' A' ' 11' ' ' THR . 3.9 t -82.66 -25.68 32.86 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-O 120.831 0.348 . . . . 0.0 110.551 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.0 m -67.55 -31.34 71.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.028 0.442 . . . . 0.0 110.108 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.96 ' O ' HG23 ' A' ' 11' ' ' THR . 1.2 t-20 -99.94 117.26 63.7 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.231 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.52 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 19.6 Cg_endo -58.38 -11.47 11.0 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.54 2.16 . . . . 0.0 113.044 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.75 -56.09 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.262 0.553 . . . . 0.0 109.628 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 4' ' ' CYS . 0.8 OUTLIER -69.44 -36.4 76.61 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.899 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.96 HG23 ' O ' ' A' ' 7' ' ' ASN . 80.4 p -44.71 -37.29 3.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.563 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 12' ' ' VAL . 8.4 t -58.11 -49.26 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.351 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -80.32 2.79 23.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.616 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -131.31 60.52 53.25 Favored Pre-proline 0 CA--C 1.529 0.164 0 CA-C-O 120.886 0.374 . . . . 0.0 110.961 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -87.89 29.63 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.912 2.408 . . . . 0.0 112.86 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.91 -23.11 15.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.322 . . . . 0.0 110.939 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.821 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -117.1 -39.92 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.016 0.436 . . . . 0.0 110.727 179.783 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.411 ' N ' HG12 ' A' ' 17' ' ' ILE . 9.7 m . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.701 0.286 . . . . 0.0 110.82 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -87.25 -44.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.809 2.339 . . . . 0.0 112.33 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.65 -12.86 17.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.943 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.927 ' HA ' HG22 ' A' ' 11' ' ' THR . 1.2 m -76.58 -23.94 53.52 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.659 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.9 t -67.34 -29.86 69.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.005 0.431 . . . . 0.0 110.331 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.911 ' O ' HG23 ' A' ' 11' ' ' THR . 0.5 OUTLIER -101.86 111.8 64.54 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.468 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.598 ' O ' HG23 ' A' ' 12' ' ' VAL . 50.9 Cg_exo -54.17 -14.52 6.47 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.552 2.168 . . . . 0.0 113.111 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.1 t -73.72 -55.62 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-O 121.336 0.589 . . . . 0.0 109.496 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.8 t -67.24 -40.85 86.36 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.457 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.927 HG22 ' HA ' ' A' ' 5' ' ' CYS . 47.3 p -44.93 -41.45 7.24 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.597 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 8' ' ' PRO . 6.6 t -52.83 -49.67 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.455 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.22 16.05 7.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.5 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.456 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 4.1 m-80 -137.27 58.13 16.65 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.767 0.318 . . . . 0.0 110.985 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.456 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 67.9 Cg_endo -89.43 28.27 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.838 2.358 . . . . 0.0 112.812 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.81 -22.82 15.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.874 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.834 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.94 -39.99 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-O 121.011 0.434 . . . . 0.0 110.707 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.407 ' N ' HG12 ' A' ' 17' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.832 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.527 0.093 0 CA-C-O 120.652 0.263 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -85.67 -46.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.703 2.269 . . . . 0.0 112.332 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.597 ' O ' ' HB3' ' A' ' 10' ' ' CYS . 1.1 m -65.28 -9.45 24.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.912 178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.2 t -84.11 -28.07 27.76 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.839 0.352 . . . . 0.0 110.715 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -73.37 -28.13 61.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.962 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -99.85 119.41 59.76 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.636 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.859 ' O ' HG22 ' A' ' 11' ' ' THR . 48.9 Cg_exo -55.77 -26.18 55.39 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.389 2.059 . . . . 0.0 112.604 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.528 HG13 ' N ' ' A' ' 10' ' ' CYS . 9.0 p -68.94 -48.23 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 121.587 0.708 . . . . 0.0 109.925 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.597 ' HB3' ' O ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER -61.26 -48.04 83.25 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.436 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.859 HG22 ' O ' ' A' ' 8' ' ' PRO . 4.0 t -44.47 -32.13 1.3 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.859 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.5 t -62.87 -52.51 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 120.95 0.405 . . . . 0.0 111.395 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -94.31 13.68 22.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.431 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.434 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 1.1 m-80 -140.13 58.04 10.19 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.799 0.333 . . . . 0.0 111.055 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.434 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 67.3 Cg_endo -88.23 22.27 0.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.743 2.296 . . . . 0.0 112.94 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -99.74 -21.3 15.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.802 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.807 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -117.95 -39.45 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.675 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 t . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.89 -179.977 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.695 0.283 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -86.74 -45.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.837 2.358 . . . . 0.0 112.408 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.1 m -64.45 -9.81 20.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.1 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.623 ' SG ' HD13 ' A' ' 17' ' ' ILE . 57.7 m -78.6 -30.4 46.59 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.433 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -68.08 -26.63 65.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.413 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -99.88 115.46 65.54 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.386 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.685 ' O ' HG22 ' A' ' 11' ' ' THR . 39.4 Cg_exo -60.32 -11.67 17.23 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.394 2.063 . . . . 0.0 113.02 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.4 t -77.68 -55.26 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.244 0.545 . . . . 0.0 109.682 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.19 -38.98 93.3 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.39 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.685 HG22 ' O ' ' A' ' 8' ' ' PRO . 2.5 t -44.95 -36.79 3.55 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.873 0.368 . . . . 0.0 111.528 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.7 t -61.62 -49.87 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.34 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -87.35 11.24 14.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.499 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.797 ' HB3' HD11 ' A' ' 17' ' ' ILE . 1.6 m-80 -132.36 65.4 74.79 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-O 120.861 0.362 . . . . 0.0 110.953 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -90.87 20.48 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.861 2.374 . . . . 0.0 112.592 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -101.03 -28.18 12.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.188 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.797 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.1 pp -110.21 -29.52 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.121 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.641 ' H ' HD12 ' A' ' 17' ' ' ILE . 20.9 p . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 110.979 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.755 0.312 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -87.77 -44.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.868 2.379 . . . . 0.0 112.298 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.1 t -62.51 -11.36 15.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.127 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.91 -27.27 28.7 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.613 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.2 m -72.8 -22.64 60.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -99.83 107.34 45.87 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.698 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.743 ' O ' HG22 ' A' ' 11' ' ' THR . 52.2 Cg_exo -54.87 -21.68 27.09 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.412 2.075 . . . . 0.0 112.543 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.8 t -74.96 -52.18 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-O 121.452 0.644 . . . . 0.0 109.389 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.9 t -63.44 -41.57 98.67 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.282 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.743 HG22 ' O ' ' A' ' 8' ' ' PRO . 1.6 t -45.35 -36.58 4.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.849 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 t -58.82 -55.43 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.375 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -66.53 -15.4 63.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.214 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.778 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -122.64 76.5 46.65 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.208 -179.747 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -91.16 26.93 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.964 2.443 . . . . 0.0 112.624 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -106.34 -27.78 10.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.242 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.778 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.0 OUTLIER -108.91 -28.0 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.196 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.504 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.867 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.733 0.301 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -86.5 -44.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.793 2.328 . . . . 0.0 112.319 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -66.1 -8.81 25.88 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.143 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.92 -24.82 32.9 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.598 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.61 -31.57 71.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.983 0.421 . . . . 0.0 110.26 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -99.97 134.91 20.6 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.379 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.684 ' O ' HG22 ' A' ' 11' ' ' THR . 74.0 Cg_endo -75.63 -1.92 11.95 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.341 2.027 . . . . 0.0 112.914 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t -84.78 -58.99 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.222 0.534 . . . . 0.0 109.693 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -61.51 -30.83 70.87 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.496 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.684 HG22 ' O ' ' A' ' 8' ' ' PRO . 14.6 t -44.75 -39.19 4.99 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.855 0.359 . . . . 0.0 111.743 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 t -59.8 -50.61 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.188 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.6 -3.19 39.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.46 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.416 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -131.94 59.49 44.88 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-O 120.82 0.343 . . . . 0.0 111.08 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.416 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 65.7 Cg_endo -88.65 27.91 0.5 Allowed 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.817 2.344 . . . . 0.0 112.812 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -99.84 -23.11 15.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 110.878 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.821 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.71 -39.83 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.696 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.413 ' N ' HG12 ' A' ' 17' ' ' ILE . 12.4 m . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.889 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.681 0.277 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -86.95 -46.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.818 2.345 . . . . 0.0 112.483 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.584 ' O ' ' HB3' ' A' ' 10' ' ' CYS . 1.2 m -64.12 -9.82 18.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.12 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.1 m -83.26 -25.72 31.38 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.791 0.329 . . . . 0.0 110.838 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -31.03 66.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.82 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -99.87 138.6 20.38 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.694 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.829 ' O ' HG22 ' A' ' 11' ' ' THR . 59.1 Cg_endo -71.97 -22.77 22.68 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.359 2.039 . . . . 0.0 112.476 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.2 t -73.17 -50.71 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.584 ' HB3' ' O ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -57.29 -47.21 82.07 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.334 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.829 HG22 ' O ' ' A' ' 8' ' ' PRO . 4.9 t -44.68 -33.71 1.94 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.83 -178.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 t -66.96 -55.95 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.135 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -71.25 -9.84 58.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.251 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.803 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -124.58 71.7 58.7 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-O 120.812 0.339 . . . . 0.0 111.037 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -90.98 18.78 1.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.84 2.36 . . . . 0.0 112.566 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -99.98 -28.33 13.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.199 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.803 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.2 pp -110.32 -29.34 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.092 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.619 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.854 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.623 0.249 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -86.1 -46.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.662 2.241 . . . . 0.0 112.556 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.2 m -67.52 -7.27 24.53 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.194 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.9 t -85.27 -28.91 25.01 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.764 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.4 m -69.0 -30.83 69.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.531 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -99.94 133.23 21.79 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.47 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.582 ' O ' HG22 ' A' ' 11' ' ' THR . 74.0 Cg_endo -75.52 -1.78 11.76 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.358 2.039 . . . . 0.0 112.926 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t -84.18 -58.57 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 121.264 0.554 . . . . 0.0 109.671 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 t -64.29 -33.16 75.18 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.444 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.582 HG22 ' O ' ' A' ' 8' ' ' PRO . 6.5 t -44.68 -39.94 5.52 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.961 0.41 . . . . 0.0 111.728 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.4 ' H ' HG23 ' A' ' 12' ' ' VAL . 3.4 t -60.26 -53.37 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.511 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -84.68 5.59 27.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.698 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.555 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -135.68 54.61 10.62 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.737 0.303 . . . . 0.0 111.181 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 61.1 Cg_endo -89.31 21.46 0.94 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.844 2.363 . . . . 0.0 112.74 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -107.49 -9.16 16.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.699 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.555 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.1 pp -112.33 -28.89 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.771 0.319 . . . . 0.0 111.216 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.471 ' N ' HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.876 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.588 ' OD1' HG21 ' A' ' 17' ' ' ILE . 0.4 OUTLIER . . . . . 0 CA--C 1.527 0.09 0 CA-C-O 120.721 0.296 . . . . 0.0 110.941 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -87.01 -44.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.866 2.377 . . . . 0.0 112.379 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -66.84 -7.74 23.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.272 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.504 ' HB2' HD13 ' A' ' 17' ' ' ILE . 49.1 t -84.96 -26.21 27.31 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.636 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.9 -31.5 70.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.372 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -99.89 134.94 20.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.433 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.646 ' O ' HG22 ' A' ' 11' ' ' THR . 73.5 Cg_endo -76.01 -1.46 11.44 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.321 2.014 . . . . 0.0 112.869 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.5 t -84.91 -59.03 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 121.248 0.547 . . . . 0.0 109.719 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -62.99 -30.29 71.48 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.534 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 8' ' ' PRO . 14.6 t -44.84 -39.79 5.64 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.825 0.345 . . . . 0.0 111.759 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.406 ' H ' HG23 ' A' ' 12' ' ' VAL . 7.1 t -57.67 -50.45 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.279 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -78.51 -3.26 42.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.347 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.407 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -132.18 60.62 52.34 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-O 120.8 0.333 . . . . 0.0 110.965 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -87.89 38.58 0.5 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.853 2.369 . . . . 0.0 112.646 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -116.28 -18.06 10.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.404 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.588 HG21 ' OD1' ' A' ' 2' ' ' ASP . 1.0 OUTLIER -110.86 -27.55 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.729 0.299 . . . . 0.0 111.191 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.437 ' H ' HD12 ' A' ' 17' ' ' ILE . 29.8 p . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.895 0.378 . . . . 0.0 110.912 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.404 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.724 0.297 . . . . 0.0 110.866 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 2' ' ' ASP . 87.8 Cg_endo -86.41 -45.43 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.824 2.35 . . . . 0.0 112.371 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.15 -10.19 21.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.07 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 52.3 t -79.21 -27.17 42.51 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.579 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.97 -28.27 67.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.412 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -99.82 130.39 26.57 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.452 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.788 ' O ' HG22 ' A' ' 11' ' ' THR . 56.5 Cg_endo -70.54 -13.03 32.34 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.367 2.045 . . . . 0.0 112.811 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.542 HG13 ' N ' ' A' ' 10' ' ' CYS . 9.8 p -76.54 -50.13 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 121.293 0.568 . . . . 0.0 110.887 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.542 ' N ' HG13 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -69.63 -34.75 74.49 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.627 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.788 HG22 ' O ' ' A' ' 8' ' ' PRO . 6.3 t -44.64 -34.61 2.26 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.805 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 t -60.52 -52.09 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.301 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.3 -5.15 57.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.399 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.526 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -132.69 62.06 60.35 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 120.831 0.348 . . . . 0.0 110.866 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -90.33 21.0 0.92 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.82 2.347 . . . . 0.0 112.879 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -99.85 -19.33 16.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.009 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.812 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.18 -39.81 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 121.032 0.444 . . . . 0.0 110.608 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.416 ' N ' HG12 ' A' ' 17' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.413 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.981 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.501 ' OD2' HG21 ' A' ' 17' ' ' ILE . 3.6 m-20 . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.688 0.28 . . . . 0.0 110.804 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -88.08 -45.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.826 2.351 . . . . 0.0 112.549 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.88 -10.62 13.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.253 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -30.51 46.2 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.89 0.376 . . . . 0.0 110.573 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 t -70.83 -23.29 62.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.812 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -99.84 116.47 64.69 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.482 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.672 ' O ' HG22 ' A' ' 11' ' ' THR . 34.8 Cg_exo -60.76 -12.61 22.46 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.456 2.104 . . . . 0.0 112.954 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.48 -54.67 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 121.305 0.574 . . . . 0.0 109.765 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.74 -37.87 89.07 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.494 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.672 HG22 ' O ' ' A' ' 8' ' ' PRO . 2.5 t -44.87 -37.05 3.62 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.837 0.351 . . . . 0.0 111.752 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.0 t -59.24 -50.37 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.339 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -95.55 21.31 8.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.357 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.567 ' HB3' HD11 ' A' ' 17' ' ' ILE . 3.0 m-80 -136.63 55.73 11.74 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.707 0.289 . . . . 0.0 111.153 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 64.1 Cg_endo -90.16 20.32 1.04 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.8 2.333 . . . . 0.0 112.787 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -99.83 -20.13 16.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.9 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.805 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.62 -39.52 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.038 0.447 . . . . 0.0 110.611 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.5 m . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.863 -179.965 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.69 0.281 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -86.55 -45.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.809 2.339 . . . . 0.0 112.333 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.69 -10.9 21.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.088 178.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.9 t -80.54 -23.65 39.85 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.663 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.8 t -69.31 -28.78 66.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.572 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -99.84 135.86 20.37 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.495 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.599 ' O ' HG22 ' A' ' 11' ' ' THR . 72.6 Cg_endo -74.99 -3.02 13.31 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.328 2.019 . . . . 0.0 112.902 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.7 t -83.11 -57.73 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-O 121.349 0.595 . . . . 0.0 109.552 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.86 -36.88 82.54 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.346 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 8' ' ' PRO . 6.1 t -44.81 -40.1 5.86 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.926 0.393 . . . . 0.0 111.683 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.9 t -60.06 -52.71 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.364 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -80.07 1.08 29.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.485 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.419 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -133.83 60.01 42.94 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.809 0.337 . . . . 0.0 111.036 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 69.3 Cg_endo -89.51 33.53 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.888 2.392 . . . . 0.0 112.609 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.63 -19.96 11.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.384 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.545 HD12 ' N ' ' A' ' 18' ' ' CYS . 1.2 pp -110.53 -29.23 2.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.752 0.311 . . . . 0.0 111.057 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.545 ' N ' HD12 ' A' ' 17' ' ' ILE . 92.4 m . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.922 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.726 0.298 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -86.42 -45.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.785 2.323 . . . . 0.0 112.304 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.01 -10.42 21.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.987 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 38.0 t -77.37 -29.4 53.28 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.51 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.8 t -68.26 -26.57 65.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.539 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -99.84 116.63 64.56 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.491 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.794 ' O ' HG22 ' A' ' 11' ' ' THR . 35.8 Cg_exo -60.66 -11.56 17.83 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.452 2.102 . . . . 0.0 113.005 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.2 t -78.72 -55.07 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.278 0.561 . . . . 0.0 109.878 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.94 -34.91 78.47 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.427 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.794 HG22 ' O ' ' A' ' 8' ' ' PRO . 5.7 t -44.77 -35.72 2.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.906 0.384 . . . . 0.0 111.73 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.401 ' H ' HG23 ' A' ' 12' ' ' VAL . 7.6 t -63.34 -49.54 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.238 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -87.44 10.94 15.9 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.411 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.776 ' HB3' HD11 ' A' ' 17' ' ' ILE . 1.4 m-80 -134.09 61.92 53.88 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.777 0.322 . . . . 0.0 110.96 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -89.73 21.18 0.94 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.859 2.373 . . . . 0.0 112.7 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -103.53 -25.46 13.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.209 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.776 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.1 pp -110.92 -29.02 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.16 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.536 ' N ' HD12 ' A' ' 17' ' ' ILE . 9.7 m . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.927 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.527 0.07 0 CA-C-O 120.766 0.317 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -85.98 -44.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.689 2.259 . . . . 0.0 112.283 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.0 -7.93 26.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.073 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 46.2 t -81.19 -30.79 34.25 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.539 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.3 m -68.48 -27.81 66.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.416 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 2.7 m-80 -99.92 118.17 62.15 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.502 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.779 ' O ' HG22 ' A' ' 11' ' ' THR . 25.5 Cg_exo -62.66 -9.49 16.23 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.44 2.093 . . . . 0.0 113.035 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.6 t -80.03 -56.35 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 121.234 0.54 . . . . 0.0 109.892 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -63.55 -31.92 73.22 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.566 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.779 HG22 ' O ' ' A' ' 8' ' ' PRO . 7.0 t -44.78 -35.42 2.72 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.75 0.31 . . . . 0.0 111.634 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 12' ' ' VAL . 4.8 t -60.19 -52.12 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.035 0.445 . . . . 0.0 111.096 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -72.64 -9.17 58.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.226 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.585 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.6 OUTLIER -128.19 68.75 77.05 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-O 120.839 0.352 . . . . 0.0 110.99 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -90.7 24.99 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.828 2.352 . . . . 0.0 112.578 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -104.15 -25.7 12.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.323 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.604 HD12 ' N ' ' A' ' 18' ' ' CYS . 1.2 pp -110.23 -29.96 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.815 0.34 . . . . 0.0 111.136 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.604 ' N ' HD12 ' A' ' 17' ' ' ILE . 52.5 m . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.805 0.335 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.475 ' OD2' HG21 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -75.99 164.01 63.08 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -86.33 -45.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.779 2.32 . . . . 0.0 112.365 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.76 -8.85 23.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.09 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.07 -28.64 35.2 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.556 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -68.29 -27.3 66.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.421 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -99.85 118.0 62.51 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.416 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.717 ' O ' HG22 ' A' ' 11' ' ' THR . 26.2 Cg_exo -62.29 -9.92 16.79 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.469 2.113 . . . . 0.0 113.022 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.5 t -78.76 -55.87 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.272 0.558 . . . . 0.0 109.813 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 t -63.24 -36.63 84.28 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.432 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.717 HG22 ' O ' ' A' ' 8' ' ' PRO . 3.9 t -44.72 -37.01 3.43 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.881 0.372 . . . . 0.0 111.731 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.0 t -63.14 -52.42 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.337 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.75 -0.47 34.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.505 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.619 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -131.98 61.6 58.91 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 120.864 0.364 . . . . 0.0 111.036 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -89.11 30.33 0.42 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.912 2.408 . . . . 0.0 112.668 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -111.3 -21.13 12.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.324 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.619 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.1 pp -110.86 -28.1 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.788 0.328 . . . . 0.0 111.201 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.458 ' N ' HD12 ' A' ' 17' ' ' ILE . 80.4 m -89.78 -23.19 21.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.916 0.389 . . . . 0.0 110.937 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.359 0 O-C-N 122.043 -0.411 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.894 0.378 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.27 175.41 0.41 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.904 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -88.27 -45.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.858 2.372 . . . . 0.0 112.447 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -56.46 -17.87 9.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.8 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.732 ' HA ' HG22 ' A' ' 11' ' ' THR . 36.2 t -68.58 -24.58 64.62 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.63 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 97.3 p -69.77 -29.48 66.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.772 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.981 ' O ' HG23 ' A' ' 11' ' ' THR . 3.1 m-80 -99.95 105.02 32.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.713 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.501 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 17.9 Cg_endo -59.57 1.34 0.4 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.854 2.37 . . . . 0.0 113.873 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.7 t -80.48 -56.51 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.128 0.49 . . . . 0.0 110.249 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.6 p -79.88 -28.85 39.89 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.423 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.981 HG23 ' O ' ' A' ' 7' ' ' ASN . 65.2 p -44.59 -32.87 1.58 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.672 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.418 ' H ' HG23 ' A' ' 12' ' ' VAL . 9.4 t -54.68 -49.5 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 121.027 0.441 . . . . 0.0 111.259 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -76.95 -4.42 43.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.414 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.619 ' HB3' HD11 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -129.07 65.74 74.7 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.835 0.35 . . . . 0.0 111.021 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -89.14 22.85 0.78 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.868 2.379 . . . . 0.0 112.853 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -99.8 -20.56 16.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 0.0 110.846 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.819 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -118.77 -39.37 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 121.062 0.458 . . . . 0.0 110.729 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.403 ' N ' HG12 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -93.17 37.52 1.04 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.944 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.341 0 O-C-N 122.018 -0.426 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 10.6 mtp180 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.807 0.337 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.25 169.33 1.27 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -85.94 -44.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.779 2.32 . . . . 0.0 112.345 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -68.29 -6.86 26.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.031 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.811 ' HA ' HG22 ' A' ' 11' ' ' THR . 51.6 t -84.54 -25.38 28.8 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.502 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.5 m -68.55 -31.25 70.33 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.025 0.44 . . . . 0.0 110.296 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.901 ' O ' HG23 ' A' ' 11' ' ' THR . 16.3 m-80 -100.44 115.86 64.97 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.462 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.515 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 52.3 Cg_exo -54.7 -14.63 7.9 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.591 2.194 . . . . 0.0 113.118 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t -76.48 -56.48 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.285 0.564 . . . . 0.0 109.733 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.06 -33.06 71.44 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.936 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.901 HG23 ' O ' ' A' ' 7' ' ' ASN . 54.5 p -44.82 -41.76 7.3 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.545 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.432 ' H ' HG23 ' A' ' 12' ' ' VAL . 4.2 t -53.88 -52.1 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.251 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 20.1 m80 -66.23 -14.02 61.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.209 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.544 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -120.58 73.37 22.51 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-O 120.779 0.324 . . . . 0.0 111.037 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.559 ' HA ' ' N ' ' A' ' 19' ' ' NH2 . 64.3 Cg_endo -90.17 28.43 0.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.907 2.405 . . . . 0.0 112.726 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -99.8 -22.59 15.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.982 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.838 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.13 -40.19 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.03 0.443 . . . . 0.0 110.751 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.407 ' N ' HG12 ' A' ' 17' ' ' ILE . 26.8 p -150.01 40.51 0.8 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.824 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . 0.559 ' N ' ' HA ' ' A' ' 15' ' ' PRO . . . . . . . . 0 C--N 1.328 -0.352 0 O-C-N 122.037 -0.415 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.804 0.335 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.55 175.23 4.83 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -87.61 -44.41 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.924 2.416 . . . . 0.0 112.371 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.32 -13.0 15.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.018 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -74.56 -27.79 60.66 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.529 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.82 -24.91 64.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.551 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -99.87 119.13 60.45 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.493 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.791 ' O ' HG22 ' A' ' 11' ' ' THR . 34.3 Cg_exo -60.84 -12.42 22.0 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.457 2.105 . . . . 0.0 113.003 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 36.2 t -77.37 -53.38 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.23 0.538 . . . . 0.0 109.993 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.97 -37.14 86.31 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.489 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.791 HG22 ' O ' ' A' ' 8' ' ' PRO . 5.5 t -44.8 -35.41 2.73 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.3 t -59.86 -48.74 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 121.051 0.453 . . . . 0.0 111.298 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -89.6 15.58 9.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.375 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.462 ' HB3' HD11 ' A' ' 17' ' ' ILE . 2.0 m-80 -140.04 58.29 10.8 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.754 0.311 . . . . 0.0 110.935 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 68.9 Cg_endo -89.27 24.55 0.66 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.799 2.333 . . . . 0.0 112.843 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -99.74 -21.91 15.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.864 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.818 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -117.4 -39.6 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.706 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.41 ' N ' HG12 ' A' ' 17' ' ' ILE . 2.1 m -103.66 143.25 33.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.904 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.376 0 O-C-N 122.07 -0.393 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.86 0.362 . . . . 0.0 111.172 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.37 161.66 13.12 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -87.81 -44.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.88 2.387 . . . . 0.0 112.324 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.5 m -63.89 -10.11 19.01 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.213 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.22 -30.78 43.42 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.671 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.7 t -68.14 -28.29 67.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.549 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -99.86 127.69 33.06 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.414 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.604 ' O ' HG22 ' A' ' 11' ' ' THR . 59.0 Cg_endo -71.82 -5.8 17.82 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.31 2.007 . . . . 0.0 112.81 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.8 t -82.09 -57.44 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.298 0.57 . . . . 0.0 109.539 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 t -63.82 -35.5 80.81 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.54 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.604 HG22 ' O ' ' A' ' 8' ' ' PRO . 5.3 t -44.8 -39.07 4.97 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.94 0.4 . . . . 0.0 111.638 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 t -60.63 -52.1 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.382 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -79.34 0.52 28.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.469 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.804 ' HB3' HD11 ' A' ' 17' ' ' ILE . 2.6 m-80 -127.7 67.27 72.54 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.786 0.327 . . . . 0.0 110.934 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -89.43 19.18 1.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.804 2.336 . . . . 0.0 112.654 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -99.99 -28.94 12.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.131 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.804 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.1 pp -110.83 -29.13 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.106 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.562 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -98.34 161.77 13.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.856 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.319 0 O-C-N 122.077 -0.389 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.856 0.36 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.99 162.22 73.59 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -86.78 -44.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.82 2.347 . . . . 0.0 112.392 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -67.37 -7.51 25.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.196 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -82.07 -35.6 28.51 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.385 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.7 t -70.06 -23.4 63.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.651 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.81 114.02 65.42 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.446 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.675 ' O ' HG22 ' A' ' 11' ' ' THR . 38.7 Cg_exo -60.27 -12.48 20.14 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.48 2.12 . . . . 0.0 112.989 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.82 -55.13 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.3 0.571 . . . . 0.0 109.763 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.37 -36.75 84.95 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.508 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 8' ' ' PRO . 2.8 t -44.87 -36.72 3.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.96 0.409 . . . . 0.0 111.627 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -61.83 -50.91 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.396 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -82.6 4.86 22.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.457 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.812 ' HB3' HD11 ' A' ' 17' ' ' ILE . 1.2 m-80 -129.54 68.17 80.01 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.837 0.351 . . . . 0.0 110.906 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -90.06 19.93 1.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.874 2.383 . . . . 0.0 112.707 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -99.88 -30.38 12.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.812 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.2 pp -111.47 -29.67 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.04 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.707 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -108.07 -97.39 0.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.842 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.343 0 O-C-N 122.009 -0.432 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 6.2 mtt85 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.808 0.337 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.97 149.73 96.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -88.06 -45.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.855 2.37 . . . . 0.0 112.584 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 10' ' ' CYS . 1.1 m -63.75 -9.99 17.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.318 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.871 ' HA ' HG22 ' A' ' 11' ' ' THR . 3.9 t -82.66 -25.68 32.86 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-O 120.831 0.348 . . . . 0.0 110.551 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.0 m -67.55 -31.34 71.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.028 0.442 . . . . 0.0 110.108 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.96 ' O ' HG23 ' A' ' 11' ' ' THR . 1.2 t-20 -99.94 117.26 63.7 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.231 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.52 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 19.6 Cg_endo -58.38 -11.47 11.0 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.54 2.16 . . . . 0.0 113.044 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.75 -56.09 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.262 0.553 . . . . 0.0 109.628 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 4' ' ' CYS . 0.8 OUTLIER -69.44 -36.4 76.61 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.899 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.96 HG23 ' O ' ' A' ' 7' ' ' ASN . 80.4 p -44.71 -37.29 3.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.563 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 12' ' ' VAL . 8.4 t -58.11 -49.26 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.351 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -80.32 2.79 23.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.616 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -131.31 60.52 53.25 Favored Pre-proline 0 CA--C 1.529 0.164 0 CA-C-O 120.886 0.374 . . . . 0.0 110.961 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -87.89 29.63 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.912 2.408 . . . . 0.0 112.86 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.91 -23.11 15.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.322 . . . . 0.0 110.939 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.821 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -117.1 -39.92 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.016 0.436 . . . . 0.0 110.727 179.783 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.411 ' N ' HG12 ' A' ' 17' ' ' ILE . 9.7 m -73.23 140.59 47.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.896 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.35 0 O-C-N 122.059 -0.401 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 77.6 mtt-85 . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.802 0.334 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.03 167.96 2.47 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.82 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -87.25 -44.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.809 2.339 . . . . 0.0 112.33 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.65 -12.86 17.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.943 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.927 ' HA ' HG22 ' A' ' 11' ' ' THR . 1.2 m -76.58 -23.94 53.52 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.659 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.9 t -67.34 -29.86 69.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.005 0.431 . . . . 0.0 110.331 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.911 ' O ' HG23 ' A' ' 11' ' ' THR . 0.5 OUTLIER -101.86 111.8 64.54 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.468 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.598 ' O ' HG23 ' A' ' 12' ' ' VAL . 50.9 Cg_exo -54.17 -14.52 6.47 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.552 2.168 . . . . 0.0 113.111 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.1 t -73.72 -55.62 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-O 121.336 0.589 . . . . 0.0 109.496 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.8 t -67.24 -40.85 86.36 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.457 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.927 HG22 ' HA ' ' A' ' 5' ' ' CYS . 47.3 p -44.93 -41.45 7.24 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.597 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 8' ' ' PRO . 6.6 t -52.83 -49.67 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.455 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.22 16.05 7.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.5 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.456 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 4.1 m-80 -137.27 58.13 16.65 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.767 0.318 . . . . 0.0 110.985 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.456 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 67.9 Cg_endo -89.43 28.27 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.838 2.358 . . . . 0.0 112.812 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.81 -22.82 15.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.874 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.834 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.94 -39.99 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-O 121.011 0.434 . . . . 0.0 110.707 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.407 ' N ' HG12 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -72.05 107.6 4.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.832 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.349 0 O-C-N 122.066 -0.396 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.6 mpp_? . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.817 0.342 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.8 166.31 3.61 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.878 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -85.67 -46.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.703 2.269 . . . . 0.0 112.332 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.597 ' O ' ' HB3' ' A' ' 10' ' ' CYS . 1.1 m -65.28 -9.45 24.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.912 178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.2 t -84.11 -28.07 27.76 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.839 0.352 . . . . 0.0 110.715 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -73.37 -28.13 61.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.962 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -99.85 119.41 59.76 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.636 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.859 ' O ' HG22 ' A' ' 11' ' ' THR . 48.9 Cg_exo -55.77 -26.18 55.39 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.389 2.059 . . . . 0.0 112.604 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.528 HG13 ' N ' ' A' ' 10' ' ' CYS . 9.0 p -68.94 -48.23 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 121.587 0.708 . . . . 0.0 109.925 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.597 ' HB3' ' O ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER -61.26 -48.04 83.25 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.436 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.859 HG22 ' O ' ' A' ' 8' ' ' PRO . 4.0 t -44.47 -32.13 1.3 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.859 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.5 t -62.87 -52.51 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 120.95 0.405 . . . . 0.0 111.395 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -94.31 13.68 22.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.431 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.434 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 1.1 m-80 -140.13 58.04 10.19 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.799 0.333 . . . . 0.0 111.055 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.434 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 67.3 Cg_endo -88.23 22.27 0.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.743 2.296 . . . . 0.0 112.94 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -99.74 -21.3 15.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.802 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.807 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -117.95 -39.45 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.675 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 t -97.2 -163.67 1.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.89 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.348 0 O-C-N 122.077 -0.389 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.78 0.324 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.82 172.05 1.25 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.845 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -86.74 -45.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.837 2.358 . . . . 0.0 112.408 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.1 m -64.45 -9.81 20.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.1 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.623 ' SG ' HD13 ' A' ' 17' ' ' ILE . 57.7 m -78.6 -30.4 46.59 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.433 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -68.08 -26.63 65.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.413 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -99.88 115.46 65.54 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.386 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.685 ' O ' HG22 ' A' ' 11' ' ' THR . 39.4 Cg_exo -60.32 -11.67 17.23 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.394 2.063 . . . . 0.0 113.02 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.4 t -77.68 -55.26 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.244 0.545 . . . . 0.0 109.682 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.19 -38.98 93.3 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.39 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.685 HG22 ' O ' ' A' ' 8' ' ' PRO . 2.5 t -44.95 -36.79 3.55 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.873 0.368 . . . . 0.0 111.528 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.7 t -61.62 -49.87 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.34 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -87.35 11.24 14.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.499 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.797 ' HB3' HD11 ' A' ' 17' ' ' ILE . 1.6 m-80 -132.36 65.4 74.79 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-O 120.861 0.362 . . . . 0.0 110.953 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -90.87 20.48 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.861 2.374 . . . . 0.0 112.592 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -101.03 -28.18 12.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.188 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.797 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.1 pp -110.21 -29.52 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.121 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.641 ' H ' HD12 ' A' ' 17' ' ' ILE . 20.9 p -164.44 -50.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 110.979 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . 0.444 ' N ' ' O ' ' A' ' 14' ' ' ASN . . . . . . . . 0 C--N 1.327 -0.379 0 O-C-N 122.083 -0.386 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.766 0.317 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.91 149.38 53.3 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -87.77 -44.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.868 2.379 . . . . 0.0 112.298 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.1 t -62.51 -11.36 15.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.127 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.91 -27.27 28.7 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.613 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.2 m -72.8 -22.64 60.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -99.83 107.34 45.87 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.698 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.743 ' O ' HG22 ' A' ' 11' ' ' THR . 52.2 Cg_exo -54.87 -21.68 27.09 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.412 2.075 . . . . 0.0 112.543 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.8 t -74.96 -52.18 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-O 121.452 0.644 . . . . 0.0 109.389 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.9 t -63.44 -41.57 98.67 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.282 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.743 HG22 ' O ' ' A' ' 8' ' ' PRO . 1.6 t -45.35 -36.58 4.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.849 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 t -58.82 -55.43 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.375 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -66.53 -15.4 63.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.214 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.778 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -122.64 76.5 46.65 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.208 -179.747 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -91.16 26.93 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.964 2.443 . . . . 0.0 112.624 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -106.34 -27.78 10.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.242 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.778 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.0 OUTLIER -108.91 -28.0 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.196 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.504 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.6 OUTLIER -107.11 -77.93 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.867 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.34 0 O-C-N 122.024 -0.422 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.871 0.367 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.85 174.16 0.48 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -86.5 -44.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.793 2.328 . . . . 0.0 112.319 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -66.1 -8.81 25.88 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.143 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.92 -24.82 32.9 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.598 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.61 -31.57 71.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.983 0.421 . . . . 0.0 110.26 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -99.97 134.91 20.6 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.379 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.684 ' O ' HG22 ' A' ' 11' ' ' THR . 74.0 Cg_endo -75.63 -1.92 11.95 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.341 2.027 . . . . 0.0 112.914 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t -84.78 -58.99 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.222 0.534 . . . . 0.0 109.693 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -61.51 -30.83 70.87 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.496 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.684 HG22 ' O ' ' A' ' 8' ' ' PRO . 14.6 t -44.75 -39.19 4.99 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.855 0.359 . . . . 0.0 111.743 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 t -59.8 -50.61 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.188 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.6 -3.19 39.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.46 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.416 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -131.94 59.49 44.88 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-O 120.82 0.343 . . . . 0.0 111.08 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.416 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 65.7 Cg_endo -88.65 27.91 0.5 Allowed 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.817 2.344 . . . . 0.0 112.812 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -99.84 -23.11 15.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 110.878 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.821 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.71 -39.83 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.696 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.413 ' N ' HG12 ' A' ' 17' ' ' ILE . 12.4 m -80.87 79.43 7.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.889 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.372 0 O-C-N 122.103 -0.373 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.835 0.35 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -59.89 158.35 25.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -86.95 -46.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.818 2.345 . . . . 0.0 112.483 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.584 ' O ' ' HB3' ' A' ' 10' ' ' CYS . 1.2 m -64.12 -9.82 18.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.12 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.1 m -83.26 -25.72 31.38 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.791 0.329 . . . . 0.0 110.838 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -31.03 66.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.82 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -99.87 138.6 20.38 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.694 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.829 ' O ' HG22 ' A' ' 11' ' ' THR . 59.1 Cg_endo -71.97 -22.77 22.68 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.359 2.039 . . . . 0.0 112.476 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.2 t -73.17 -50.71 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.584 ' HB3' ' O ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -57.29 -47.21 82.07 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.334 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.829 HG22 ' O ' ' A' ' 8' ' ' PRO . 4.9 t -44.68 -33.71 1.94 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.83 -178.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 t -66.96 -55.95 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.135 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -71.25 -9.84 58.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.251 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.803 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -124.58 71.7 58.7 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-O 120.812 0.339 . . . . 0.0 111.037 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -90.98 18.78 1.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.84 2.36 . . . . 0.0 112.566 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -99.98 -28.33 13.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.199 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.803 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.2 pp -110.32 -29.34 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.092 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.619 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -104.63 151.05 24.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.854 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.353 0 O-C-N 122.083 -0.385 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.817 0.341 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -77.84 146.43 72.27 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.857 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -86.1 -46.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.662 2.241 . . . . 0.0 112.556 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.2 m -67.52 -7.27 24.53 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.194 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.9 t -85.27 -28.91 25.01 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.764 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.4 m -69.0 -30.83 69.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.531 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -99.94 133.23 21.79 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.47 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.582 ' O ' HG22 ' A' ' 11' ' ' THR . 74.0 Cg_endo -75.52 -1.78 11.76 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.358 2.039 . . . . 0.0 112.926 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t -84.18 -58.57 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 121.264 0.554 . . . . 0.0 109.671 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 t -64.29 -33.16 75.18 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.444 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.582 HG22 ' O ' ' A' ' 8' ' ' PRO . 6.5 t -44.68 -39.94 5.52 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.961 0.41 . . . . 0.0 111.728 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.4 ' H ' HG23 ' A' ' 12' ' ' VAL . 3.4 t -60.26 -53.37 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.511 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -84.68 5.59 27.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.698 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.555 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -135.68 54.61 10.62 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.737 0.303 . . . . 0.0 111.181 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 61.1 Cg_endo -89.31 21.46 0.94 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.844 2.363 . . . . 0.0 112.74 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -107.49 -9.16 16.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.699 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.555 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.1 pp -112.33 -28.89 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.771 0.319 . . . . 0.0 111.216 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.471 ' N ' HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -127.38 -48.67 1.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.876 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 O-C-N 122.047 -0.408 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.804 0.335 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.588 ' OD1' HG21 ' A' ' 17' ' ' ILE . 0.4 OUTLIER -72.01 152.48 92.85 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.941 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -87.01 -44.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.866 2.377 . . . . 0.0 112.379 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -66.84 -7.74 23.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.272 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.504 ' HB2' HD13 ' A' ' 17' ' ' ILE . 49.1 t -84.96 -26.21 27.31 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.636 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.9 -31.5 70.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.372 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -99.89 134.94 20.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.433 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.646 ' O ' HG22 ' A' ' 11' ' ' THR . 73.5 Cg_endo -76.01 -1.46 11.44 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.321 2.014 . . . . 0.0 112.869 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.5 t -84.91 -59.03 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 121.248 0.547 . . . . 0.0 109.719 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -62.99 -30.29 71.48 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.534 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 8' ' ' PRO . 14.6 t -44.84 -39.79 5.64 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.825 0.345 . . . . 0.0 111.759 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.406 ' H ' HG23 ' A' ' 12' ' ' VAL . 7.1 t -57.67 -50.45 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.279 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -78.51 -3.26 42.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.347 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.407 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -132.18 60.62 52.34 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-O 120.8 0.333 . . . . 0.0 110.965 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -87.89 38.58 0.5 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.853 2.369 . . . . 0.0 112.646 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -116.28 -18.06 10.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.404 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.588 HG21 ' OD1' ' A' ' 2' ' ' ASP . 1.0 OUTLIER -110.86 -27.55 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.729 0.299 . . . . 0.0 111.191 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.437 ' H ' HD12 ' A' ' 17' ' ' ILE . 29.8 p -169.33 14.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.895 0.378 . . . . 0.0 110.912 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.352 0 O-C-N 122.077 -0.389 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.776 0.322 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.404 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.2 OUTLIER -84.92 175.97 4.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 2' ' ' ASP . 87.8 Cg_endo -86.41 -45.43 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.824 2.35 . . . . 0.0 112.371 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.15 -10.19 21.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.07 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 52.3 t -79.21 -27.17 42.51 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.579 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.97 -28.27 67.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.412 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -99.82 130.39 26.57 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.452 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.788 ' O ' HG22 ' A' ' 11' ' ' THR . 56.5 Cg_endo -70.54 -13.03 32.34 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.367 2.045 . . . . 0.0 112.811 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.542 HG13 ' N ' ' A' ' 10' ' ' CYS . 9.8 p -76.54 -50.13 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 121.293 0.568 . . . . 0.0 110.887 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.542 ' N ' HG13 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -69.63 -34.75 74.49 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.627 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.788 HG22 ' O ' ' A' ' 8' ' ' PRO . 6.3 t -44.64 -34.61 2.26 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.805 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 t -60.52 -52.09 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.301 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.3 -5.15 57.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.399 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.526 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -132.69 62.06 60.35 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 120.831 0.348 . . . . 0.0 110.866 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -90.33 21.0 0.92 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.82 2.347 . . . . 0.0 112.879 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -99.85 -19.33 16.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.009 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.812 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.18 -39.81 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 121.032 0.444 . . . . 0.0 110.608 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.416 ' N ' HG12 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -85.53 -30.98 22.97 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.981 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.343 0 O-C-N 122.04 -0.412 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.6 ptt85 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.866 0.365 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.501 ' OD2' HG21 ' A' ' 17' ' ' ILE . 3.6 m-20 -82.77 162.05 56.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.804 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -88.08 -45.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.826 2.351 . . . . 0.0 112.549 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.88 -10.62 13.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.253 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -30.51 46.2 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.89 0.376 . . . . 0.0 110.573 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 t -70.83 -23.29 62.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.812 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -99.84 116.47 64.69 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.482 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.672 ' O ' HG22 ' A' ' 11' ' ' THR . 34.8 Cg_exo -60.76 -12.61 22.46 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.456 2.104 . . . . 0.0 112.954 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.48 -54.67 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 121.305 0.574 . . . . 0.0 109.765 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.74 -37.87 89.07 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.494 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.672 HG22 ' O ' ' A' ' 8' ' ' PRO . 2.5 t -44.87 -37.05 3.62 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.837 0.351 . . . . 0.0 111.752 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.0 t -59.24 -50.37 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.339 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -95.55 21.31 8.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.357 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.567 ' HB3' HD11 ' A' ' 17' ' ' ILE . 3.0 m-80 -136.63 55.73 11.74 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.707 0.289 . . . . 0.0 111.153 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 64.1 Cg_endo -90.16 20.32 1.04 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.8 2.333 . . . . 0.0 112.787 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -99.83 -20.13 16.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.9 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.805 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.62 -39.52 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.038 0.447 . . . . 0.0 110.611 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.5 m -78.12 77.98 4.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.863 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.344 0 O-C-N 122.046 -0.408 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.6 mtp-105 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.831 0.348 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.93 168.04 5.18 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.855 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -86.55 -45.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.809 2.339 . . . . 0.0 112.333 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.69 -10.9 21.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.088 178.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.9 t -80.54 -23.65 39.85 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.663 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.8 t -69.31 -28.78 66.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.572 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -99.84 135.86 20.37 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.495 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.599 ' O ' HG22 ' A' ' 11' ' ' THR . 72.6 Cg_endo -74.99 -3.02 13.31 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.328 2.019 . . . . 0.0 112.902 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.7 t -83.11 -57.73 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-O 121.349 0.595 . . . . 0.0 109.552 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.86 -36.88 82.54 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.346 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 8' ' ' PRO . 6.1 t -44.81 -40.1 5.86 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.926 0.393 . . . . 0.0 111.683 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.9 t -60.06 -52.71 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.364 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -80.07 1.08 29.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.485 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.419 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -133.83 60.01 42.94 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.809 0.337 . . . . 0.0 111.036 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 69.3 Cg_endo -89.51 33.53 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.888 2.392 . . . . 0.0 112.609 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.63 -19.96 11.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.384 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.545 HD12 ' N ' ' A' ' 18' ' ' CYS . 1.2 pp -110.53 -29.23 2.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.752 0.311 . . . . 0.0 111.057 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.545 ' N ' HD12 ' A' ' 17' ' ' ILE . 92.4 m -133.8 105.35 6.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.922 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 O-C-N 122.066 -0.396 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.814 0.34 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.26 171.96 11.1 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.808 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -86.42 -45.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.785 2.323 . . . . 0.0 112.304 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.01 -10.42 21.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.987 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 38.0 t -77.37 -29.4 53.28 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.51 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.8 t -68.26 -26.57 65.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.539 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -99.84 116.63 64.56 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.491 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.794 ' O ' HG22 ' A' ' 11' ' ' THR . 35.8 Cg_exo -60.66 -11.56 17.83 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.452 2.102 . . . . 0.0 113.005 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.2 t -78.72 -55.07 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.278 0.561 . . . . 0.0 109.878 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.94 -34.91 78.47 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.427 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.794 HG22 ' O ' ' A' ' 8' ' ' PRO . 5.7 t -44.77 -35.72 2.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.906 0.384 . . . . 0.0 111.73 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.401 ' H ' HG23 ' A' ' 12' ' ' VAL . 7.6 t -63.34 -49.54 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.238 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -87.44 10.94 15.9 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.411 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.776 ' HB3' HD11 ' A' ' 17' ' ' ILE . 1.4 m-80 -134.09 61.92 53.88 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.777 0.322 . . . . 0.0 110.96 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -89.73 21.18 0.94 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.859 2.373 . . . . 0.0 112.7 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -103.53 -25.46 13.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.209 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.776 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.1 pp -110.92 -29.02 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.16 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.536 ' N ' HD12 ' A' ' 17' ' ' ILE . 9.7 m -138.41 -166.38 1.98 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.927 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.357 0 O-C-N 122.079 -0.388 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.828 0.347 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.92 162.81 8.81 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.813 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -85.98 -44.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.689 2.259 . . . . 0.0 112.283 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.0 -7.93 26.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.073 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 46.2 t -81.19 -30.79 34.25 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.539 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.3 m -68.48 -27.81 66.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.416 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 2.7 m-80 -99.92 118.17 62.15 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.502 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.779 ' O ' HG22 ' A' ' 11' ' ' THR . 25.5 Cg_exo -62.66 -9.49 16.23 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.44 2.093 . . . . 0.0 113.035 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.6 t -80.03 -56.35 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 121.234 0.54 . . . . 0.0 109.892 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -63.55 -31.92 73.22 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.566 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.779 HG22 ' O ' ' A' ' 8' ' ' PRO . 7.0 t -44.78 -35.42 2.72 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.75 0.31 . . . . 0.0 111.634 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 12' ' ' VAL . 4.8 t -60.19 -52.12 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.035 0.445 . . . . 0.0 111.096 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -72.64 -9.17 58.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.226 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.585 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.6 OUTLIER -128.19 68.75 77.05 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-O 120.839 0.352 . . . . 0.0 110.99 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -90.7 24.99 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.828 2.352 . . . . 0.0 112.578 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -104.15 -25.7 12.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.323 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.604 HD12 ' N ' ' A' ' 18' ' ' CYS . 1.2 pp -110.23 -29.96 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.815 0.34 . . . . 0.0 111.136 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.604 ' N ' HD12 ' A' ' 17' ' ' ILE . 52.5 m -147.08 166.08 27.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.391 0 O-C-N 122.065 -0.397 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.475 ' OD2' HG21 ' A' ' 17' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.737 0.303 . . . . 0.0 110.913 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -86.33 -45.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.779 2.32 . . . . 0.0 112.365 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.76 -8.85 23.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.09 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.07 -28.64 35.2 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.556 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -68.29 -27.3 66.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.421 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -99.85 118.0 62.51 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.416 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.717 ' O ' HG22 ' A' ' 11' ' ' THR . 26.2 Cg_exo -62.29 -9.92 16.79 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.469 2.113 . . . . 0.0 113.022 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.5 t -78.76 -55.87 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.272 0.558 . . . . 0.0 109.813 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 t -63.24 -36.63 84.28 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.432 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.717 HG22 ' O ' ' A' ' 8' ' ' PRO . 3.9 t -44.72 -37.01 3.43 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.881 0.372 . . . . 0.0 111.731 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.0 t -63.14 -52.42 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.337 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.75 -0.47 34.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.505 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.619 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -131.98 61.6 58.91 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 120.864 0.364 . . . . 0.0 111.036 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -89.11 30.33 0.42 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.912 2.408 . . . . 0.0 112.668 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -111.3 -21.13 12.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.324 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.619 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.1 pp -110.86 -28.1 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.788 0.328 . . . . 0.0 111.201 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.458 ' N ' HD12 ' A' ' 17' ' ' ILE . 80.4 m . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.916 0.389 . . . . 0.0 110.937 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.71 0.29 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -88.27 -45.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.858 2.372 . . . . 0.0 112.447 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -56.46 -17.87 9.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.8 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.732 ' HA ' HG22 ' A' ' 11' ' ' THR . 36.2 t -68.58 -24.58 64.62 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.63 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 97.3 p -69.77 -29.48 66.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.772 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.981 ' O ' HG23 ' A' ' 11' ' ' THR . 3.1 m-80 -99.95 105.02 32.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.713 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.501 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 17.9 Cg_endo -59.57 1.34 0.4 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.854 2.37 . . . . 0.0 113.873 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.7 t -80.48 -56.51 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.128 0.49 . . . . 0.0 110.249 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.6 p -79.88 -28.85 39.89 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.423 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.981 HG23 ' O ' ' A' ' 7' ' ' ASN . 65.2 p -44.59 -32.87 1.58 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.672 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.418 ' H ' HG23 ' A' ' 12' ' ' VAL . 9.4 t -54.68 -49.5 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 121.027 0.441 . . . . 0.0 111.259 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -76.95 -4.42 43.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.414 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.619 ' HB3' HD11 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -129.07 65.74 74.7 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.835 0.35 . . . . 0.0 111.021 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -89.14 22.85 0.78 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.868 2.379 . . . . 0.0 112.853 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -99.8 -20.56 16.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 0.0 110.846 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.819 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -118.77 -39.37 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 121.062 0.458 . . . . 0.0 110.729 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.403 ' N ' HG12 ' A' ' 17' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.944 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.708 0.29 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -85.94 -44.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.779 2.32 . . . . 0.0 112.345 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -68.29 -6.86 26.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.031 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.811 ' HA ' HG22 ' A' ' 11' ' ' THR . 51.6 t -84.54 -25.38 28.8 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.502 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.5 m -68.55 -31.25 70.33 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.025 0.44 . . . . 0.0 110.296 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.901 ' O ' HG23 ' A' ' 11' ' ' THR . 16.3 m-80 -100.44 115.86 64.97 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.462 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.515 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 52.3 Cg_exo -54.7 -14.63 7.9 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.591 2.194 . . . . 0.0 113.118 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t -76.48 -56.48 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.285 0.564 . . . . 0.0 109.733 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.06 -33.06 71.44 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.936 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.901 HG23 ' O ' ' A' ' 7' ' ' ASN . 54.5 p -44.82 -41.76 7.3 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.545 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.432 ' H ' HG23 ' A' ' 12' ' ' VAL . 4.2 t -53.88 -52.1 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.251 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 20.1 m80 -66.23 -14.02 61.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.209 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.544 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -120.58 73.37 22.51 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-O 120.779 0.324 . . . . 0.0 111.037 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -90.17 28.43 0.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.907 2.405 . . . . 0.0 112.726 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -99.8 -22.59 15.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.982 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.838 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.13 -40.19 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.03 0.443 . . . . 0.0 110.751 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.407 ' N ' HG12 ' A' ' 17' ' ' ILE . 26.8 p . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.824 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.735 0.302 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -87.61 -44.41 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.924 2.416 . . . . 0.0 112.371 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.32 -13.0 15.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.018 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -74.56 -27.79 60.66 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.529 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.82 -24.91 64.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.551 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -99.87 119.13 60.45 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.493 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.791 ' O ' HG22 ' A' ' 11' ' ' THR . 34.3 Cg_exo -60.84 -12.42 22.0 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.457 2.105 . . . . 0.0 113.003 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 36.2 t -77.37 -53.38 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.23 0.538 . . . . 0.0 109.993 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.97 -37.14 86.31 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.489 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.791 HG22 ' O ' ' A' ' 8' ' ' PRO . 5.5 t -44.8 -35.41 2.73 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.3 t -59.86 -48.74 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 121.051 0.453 . . . . 0.0 111.298 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -89.6 15.58 9.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.375 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.462 ' HB3' HD11 ' A' ' 17' ' ' ILE . 2.0 m-80 -140.04 58.29 10.8 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.754 0.311 . . . . 0.0 110.935 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 68.9 Cg_endo -89.27 24.55 0.66 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.799 2.333 . . . . 0.0 112.843 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -99.74 -21.91 15.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.864 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.818 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -117.4 -39.6 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.706 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.41 ' N ' HG12 ' A' ' 17' ' ' ILE . 2.1 m . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.099 0 CA-C-O 120.731 0.301 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -87.81 -44.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.88 2.387 . . . . 0.0 112.324 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.5 m -63.89 -10.11 19.01 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.213 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.22 -30.78 43.42 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.671 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.7 t -68.14 -28.29 67.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.549 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -99.86 127.69 33.06 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.414 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.604 ' O ' HG22 ' A' ' 11' ' ' THR . 59.0 Cg_endo -71.82 -5.8 17.82 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.31 2.007 . . . . 0.0 112.81 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.8 t -82.09 -57.44 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.298 0.57 . . . . 0.0 109.539 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 t -63.82 -35.5 80.81 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.54 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.604 HG22 ' O ' ' A' ' 8' ' ' PRO . 5.3 t -44.8 -39.07 4.97 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.94 0.4 . . . . 0.0 111.638 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 t -60.63 -52.1 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.382 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -79.34 0.52 28.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.469 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.804 ' HB3' HD11 ' A' ' 17' ' ' ILE . 2.6 m-80 -127.7 67.27 72.54 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.786 0.327 . . . . 0.0 110.934 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -89.43 19.18 1.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.804 2.336 . . . . 0.0 112.654 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -99.99 -28.94 12.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.131 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.804 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.1 pp -110.83 -29.13 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.106 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.562 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.856 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.748 0.309 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -86.78 -44.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.82 2.347 . . . . 0.0 112.392 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -67.37 -7.51 25.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.196 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -82.07 -35.6 28.51 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.385 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.7 t -70.06 -23.4 63.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.651 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.81 114.02 65.42 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.446 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.675 ' O ' HG22 ' A' ' 11' ' ' THR . 38.7 Cg_exo -60.27 -12.48 20.14 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.48 2.12 . . . . 0.0 112.989 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.82 -55.13 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.3 0.571 . . . . 0.0 109.763 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.37 -36.75 84.95 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.508 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 8' ' ' PRO . 2.8 t -44.87 -36.72 3.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.96 0.409 . . . . 0.0 111.627 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -61.83 -50.91 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.396 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -82.6 4.86 22.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.457 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.812 ' HB3' HD11 ' A' ' 17' ' ' ILE . 1.2 m-80 -129.54 68.17 80.01 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.837 0.351 . . . . 0.0 110.906 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -90.06 19.93 1.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.874 2.383 . . . . 0.0 112.707 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -99.88 -30.38 12.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.812 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.2 pp -111.47 -29.67 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.04 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.707 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.842 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.698 0.285 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -88.06 -45.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.855 2.37 . . . . 0.0 112.584 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 10' ' ' CYS . 1.1 m -63.75 -9.99 17.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.318 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.871 ' HA ' HG22 ' A' ' 11' ' ' THR . 3.9 t -82.66 -25.68 32.86 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-O 120.831 0.348 . . . . 0.0 110.551 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.0 m -67.55 -31.34 71.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.028 0.442 . . . . 0.0 110.108 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.96 ' O ' HG23 ' A' ' 11' ' ' THR . 1.2 t-20 -99.94 117.26 63.7 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.231 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.52 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 19.6 Cg_endo -58.38 -11.47 11.0 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.54 2.16 . . . . 0.0 113.044 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.75 -56.09 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.262 0.553 . . . . 0.0 109.628 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 4' ' ' CYS . 0.8 OUTLIER -69.44 -36.4 76.61 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.899 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.96 HG23 ' O ' ' A' ' 7' ' ' ASN . 80.4 p -44.71 -37.29 3.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.563 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 12' ' ' VAL . 8.4 t -58.11 -49.26 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.351 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -80.32 2.79 23.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.616 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -131.31 60.52 53.25 Favored Pre-proline 0 CA--C 1.529 0.164 0 CA-C-O 120.886 0.374 . . . . 0.0 110.961 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -87.89 29.63 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.912 2.408 . . . . 0.0 112.86 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.91 -23.11 15.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.322 . . . . 0.0 110.939 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.821 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -117.1 -39.92 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.016 0.436 . . . . 0.0 110.727 179.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.411 ' N ' HG12 ' A' ' 17' ' ' ILE . 9.7 m . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.701 0.286 . . . . 0.0 110.82 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -87.25 -44.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.809 2.339 . . . . 0.0 112.33 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.65 -12.86 17.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.943 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.927 ' HA ' HG22 ' A' ' 11' ' ' THR . 1.2 m -76.58 -23.94 53.52 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.659 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.9 t -67.34 -29.86 69.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.005 0.431 . . . . 0.0 110.331 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.911 ' O ' HG23 ' A' ' 11' ' ' THR . 0.5 OUTLIER -101.86 111.8 64.54 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.468 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.598 ' O ' HG23 ' A' ' 12' ' ' VAL . 50.9 Cg_exo -54.17 -14.52 6.47 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.552 2.168 . . . . 0.0 113.111 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.1 t -73.72 -55.62 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-O 121.336 0.589 . . . . 0.0 109.496 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.8 t -67.24 -40.85 86.36 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.457 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.927 HG22 ' HA ' ' A' ' 5' ' ' CYS . 47.3 p -44.93 -41.45 7.24 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.597 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 8' ' ' PRO . 6.6 t -52.83 -49.67 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.455 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.22 16.05 7.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.5 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.456 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 4.1 m-80 -137.27 58.13 16.65 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.767 0.318 . . . . 0.0 110.985 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.456 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 67.9 Cg_endo -89.43 28.27 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.838 2.358 . . . . 0.0 112.812 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.81 -22.82 15.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.874 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.834 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.94 -39.99 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-O 121.011 0.434 . . . . 0.0 110.707 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.407 ' N ' HG12 ' A' ' 17' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.832 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.527 0.093 0 CA-C-O 120.652 0.263 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -85.67 -46.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.703 2.269 . . . . 0.0 112.332 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.597 ' O ' ' HB3' ' A' ' 10' ' ' CYS . 1.1 m -65.28 -9.45 24.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.912 178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.2 t -84.11 -28.07 27.76 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.839 0.352 . . . . 0.0 110.715 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -73.37 -28.13 61.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.962 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -99.85 119.41 59.76 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.636 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.859 ' O ' HG22 ' A' ' 11' ' ' THR . 48.9 Cg_exo -55.77 -26.18 55.39 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.389 2.059 . . . . 0.0 112.604 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.528 HG13 ' N ' ' A' ' 10' ' ' CYS . 9.0 p -68.94 -48.23 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 121.587 0.708 . . . . 0.0 109.925 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.597 ' HB3' ' O ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER -61.26 -48.04 83.25 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.436 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.859 HG22 ' O ' ' A' ' 8' ' ' PRO . 4.0 t -44.47 -32.13 1.3 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.859 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.5 t -62.87 -52.51 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 120.95 0.405 . . . . 0.0 111.395 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -94.31 13.68 22.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.431 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.434 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 1.1 m-80 -140.13 58.04 10.19 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.799 0.333 . . . . 0.0 111.055 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.434 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 67.3 Cg_endo -88.23 22.27 0.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.743 2.296 . . . . 0.0 112.94 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -99.74 -21.3 15.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.802 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.807 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -117.95 -39.45 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.675 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 t . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.89 -179.977 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.695 0.283 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -86.74 -45.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.837 2.358 . . . . 0.0 112.408 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.1 m -64.45 -9.81 20.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.1 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.623 ' SG ' HD13 ' A' ' 17' ' ' ILE . 57.7 m -78.6 -30.4 46.59 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.433 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -68.08 -26.63 65.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.413 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -99.88 115.46 65.54 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.386 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.685 ' O ' HG22 ' A' ' 11' ' ' THR . 39.4 Cg_exo -60.32 -11.67 17.23 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.394 2.063 . . . . 0.0 113.02 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.4 t -77.68 -55.26 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.244 0.545 . . . . 0.0 109.682 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.19 -38.98 93.3 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.39 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.685 HG22 ' O ' ' A' ' 8' ' ' PRO . 2.5 t -44.95 -36.79 3.55 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.873 0.368 . . . . 0.0 111.528 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.7 t -61.62 -49.87 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.34 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -87.35 11.24 14.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.499 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.797 ' HB3' HD11 ' A' ' 17' ' ' ILE . 1.6 m-80 -132.36 65.4 74.79 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-O 120.861 0.362 . . . . 0.0 110.953 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -90.87 20.48 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.861 2.374 . . . . 0.0 112.592 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -101.03 -28.18 12.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.188 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.797 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.1 pp -110.21 -29.52 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.121 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.641 ' H ' HD12 ' A' ' 17' ' ' ILE . 20.9 p . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 110.979 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.755 0.312 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -87.77 -44.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.868 2.379 . . . . 0.0 112.298 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.1 t -62.51 -11.36 15.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.127 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.91 -27.27 28.7 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.613 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.2 m -72.8 -22.64 60.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -99.83 107.34 45.87 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.698 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.743 ' O ' HG22 ' A' ' 11' ' ' THR . 52.2 Cg_exo -54.87 -21.68 27.09 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.412 2.075 . . . . 0.0 112.543 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.8 t -74.96 -52.18 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-O 121.452 0.644 . . . . 0.0 109.389 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.9 t -63.44 -41.57 98.67 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.282 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.743 HG22 ' O ' ' A' ' 8' ' ' PRO . 1.6 t -45.35 -36.58 4.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.849 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 t -58.82 -55.43 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.375 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -66.53 -15.4 63.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.214 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.778 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -122.64 76.5 46.65 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.208 -179.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -91.16 26.93 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.964 2.443 . . . . 0.0 112.624 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -106.34 -27.78 10.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.242 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.778 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.0 OUTLIER -108.91 -28.0 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.196 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.504 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.867 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.733 0.301 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -86.5 -44.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.793 2.328 . . . . 0.0 112.319 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -66.1 -8.81 25.88 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.143 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.92 -24.82 32.9 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.598 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.61 -31.57 71.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.983 0.421 . . . . 0.0 110.26 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -99.97 134.91 20.6 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.379 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.684 ' O ' HG22 ' A' ' 11' ' ' THR . 74.0 Cg_endo -75.63 -1.92 11.95 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.341 2.027 . . . . 0.0 112.914 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t -84.78 -58.99 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.222 0.534 . . . . 0.0 109.693 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -61.51 -30.83 70.87 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.496 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.684 HG22 ' O ' ' A' ' 8' ' ' PRO . 14.6 t -44.75 -39.19 4.99 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.855 0.359 . . . . 0.0 111.743 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 t -59.8 -50.61 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.188 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.6 -3.19 39.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.46 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.416 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -131.94 59.49 44.88 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-O 120.82 0.343 . . . . 0.0 111.08 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.416 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 65.7 Cg_endo -88.65 27.91 0.5 Allowed 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.817 2.344 . . . . 0.0 112.812 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -99.84 -23.11 15.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 110.878 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.821 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.71 -39.83 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.696 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.413 ' N ' HG12 ' A' ' 17' ' ' ILE . 12.4 m . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.889 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.681 0.277 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -86.95 -46.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.818 2.345 . . . . 0.0 112.483 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.584 ' O ' ' HB3' ' A' ' 10' ' ' CYS . 1.2 m -64.12 -9.82 18.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.12 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.1 m -83.26 -25.72 31.38 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.791 0.329 . . . . 0.0 110.838 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -31.03 66.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.82 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -99.87 138.6 20.38 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.694 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.829 ' O ' HG22 ' A' ' 11' ' ' THR . 59.1 Cg_endo -71.97 -22.77 22.68 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.359 2.039 . . . . 0.0 112.476 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.2 t -73.17 -50.71 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.584 ' HB3' ' O ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -57.29 -47.21 82.07 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.334 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.829 HG22 ' O ' ' A' ' 8' ' ' PRO . 4.9 t -44.68 -33.71 1.94 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.83 -178.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 t -66.96 -55.95 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.135 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -71.25 -9.84 58.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.251 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.803 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -124.58 71.7 58.7 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-O 120.812 0.339 . . . . 0.0 111.037 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -90.98 18.78 1.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.84 2.36 . . . . 0.0 112.566 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -99.98 -28.33 13.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.199 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.803 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.2 pp -110.32 -29.34 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.092 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.619 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.854 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.623 0.249 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -86.1 -46.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.662 2.241 . . . . 0.0 112.556 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.2 m -67.52 -7.27 24.53 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.194 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.9 t -85.27 -28.91 25.01 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.764 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.4 m -69.0 -30.83 69.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.531 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -99.94 133.23 21.79 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.47 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.582 ' O ' HG22 ' A' ' 11' ' ' THR . 74.0 Cg_endo -75.52 -1.78 11.76 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.358 2.039 . . . . 0.0 112.926 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t -84.18 -58.57 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 121.264 0.554 . . . . 0.0 109.671 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 t -64.29 -33.16 75.18 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.444 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.582 HG22 ' O ' ' A' ' 8' ' ' PRO . 6.5 t -44.68 -39.94 5.52 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.961 0.41 . . . . 0.0 111.728 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.4 ' H ' HG23 ' A' ' 12' ' ' VAL . 3.4 t -60.26 -53.37 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.511 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -84.68 5.59 27.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.698 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.555 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -135.68 54.61 10.62 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.737 0.303 . . . . 0.0 111.181 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 61.1 Cg_endo -89.31 21.46 0.94 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.844 2.363 . . . . 0.0 112.74 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -107.49 -9.16 16.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.699 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.555 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.1 pp -112.33 -28.89 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.771 0.319 . . . . 0.0 111.216 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.471 ' N ' HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.876 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.588 ' OD1' HG21 ' A' ' 17' ' ' ILE . 0.4 OUTLIER . . . . . 0 CA--C 1.527 0.09 0 CA-C-O 120.721 0.296 . . . . 0.0 110.941 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -87.01 -44.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.866 2.377 . . . . 0.0 112.379 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -66.84 -7.74 23.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.272 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.504 ' HB2' HD13 ' A' ' 17' ' ' ILE . 49.1 t -84.96 -26.21 27.31 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.636 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.9 -31.5 70.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.372 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -99.89 134.94 20.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.433 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.646 ' O ' HG22 ' A' ' 11' ' ' THR . 73.5 Cg_endo -76.01 -1.46 11.44 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.321 2.014 . . . . 0.0 112.869 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.5 t -84.91 -59.03 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 121.248 0.547 . . . . 0.0 109.719 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -62.99 -30.29 71.48 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.534 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 8' ' ' PRO . 14.6 t -44.84 -39.79 5.64 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.825 0.345 . . . . 0.0 111.759 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.406 ' H ' HG23 ' A' ' 12' ' ' VAL . 7.1 t -57.67 -50.45 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.279 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -78.51 -3.26 42.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.347 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.407 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -132.18 60.62 52.34 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-O 120.8 0.333 . . . . 0.0 110.965 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -87.89 38.58 0.5 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.853 2.369 . . . . 0.0 112.646 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -116.28 -18.06 10.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.404 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.588 HG21 ' OD1' ' A' ' 2' ' ' ASP . 1.0 OUTLIER -110.86 -27.55 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.729 0.299 . . . . 0.0 111.191 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.437 ' H ' HD12 ' A' ' 17' ' ' ILE . 29.8 p . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.895 0.378 . . . . 0.0 110.912 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.404 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.724 0.297 . . . . 0.0 110.866 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 2' ' ' ASP . 87.8 Cg_endo -86.41 -45.43 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.824 2.35 . . . . 0.0 112.371 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.15 -10.19 21.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.07 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 52.3 t -79.21 -27.17 42.51 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.579 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.97 -28.27 67.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.412 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -99.82 130.39 26.57 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.452 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.788 ' O ' HG22 ' A' ' 11' ' ' THR . 56.5 Cg_endo -70.54 -13.03 32.34 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.367 2.045 . . . . 0.0 112.811 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.542 HG13 ' N ' ' A' ' 10' ' ' CYS . 9.8 p -76.54 -50.13 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 121.293 0.568 . . . . 0.0 110.887 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.542 ' N ' HG13 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -69.63 -34.75 74.49 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.627 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.788 HG22 ' O ' ' A' ' 8' ' ' PRO . 6.3 t -44.64 -34.61 2.26 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.805 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 t -60.52 -52.09 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.301 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.3 -5.15 57.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.399 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.526 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -132.69 62.06 60.35 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 120.831 0.348 . . . . 0.0 110.866 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -90.33 21.0 0.92 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.82 2.347 . . . . 0.0 112.879 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -99.85 -19.33 16.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.009 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.812 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.18 -39.81 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 121.032 0.444 . . . . 0.0 110.608 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.416 ' N ' HG12 ' A' ' 17' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.413 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.981 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.501 ' OD2' HG21 ' A' ' 17' ' ' ILE . 3.6 m-20 . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.688 0.28 . . . . 0.0 110.804 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -88.08 -45.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.826 2.351 . . . . 0.0 112.549 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.88 -10.62 13.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.253 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -30.51 46.2 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.89 0.376 . . . . 0.0 110.573 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 t -70.83 -23.29 62.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.812 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -99.84 116.47 64.69 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.482 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.672 ' O ' HG22 ' A' ' 11' ' ' THR . 34.8 Cg_exo -60.76 -12.61 22.46 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.456 2.104 . . . . 0.0 112.954 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.48 -54.67 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 121.305 0.574 . . . . 0.0 109.765 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.74 -37.87 89.07 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.494 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.672 HG22 ' O ' ' A' ' 8' ' ' PRO . 2.5 t -44.87 -37.05 3.62 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.837 0.351 . . . . 0.0 111.752 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.0 t -59.24 -50.37 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.339 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -95.55 21.31 8.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.357 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.567 ' HB3' HD11 ' A' ' 17' ' ' ILE . 3.0 m-80 -136.63 55.73 11.74 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.707 0.289 . . . . 0.0 111.153 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 64.1 Cg_endo -90.16 20.32 1.04 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.8 2.333 . . . . 0.0 112.787 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -99.83 -20.13 16.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.9 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.805 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.62 -39.52 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.038 0.447 . . . . 0.0 110.611 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.5 m . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.863 -179.965 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.69 0.281 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -86.55 -45.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.809 2.339 . . . . 0.0 112.333 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.69 -10.9 21.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.088 178.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.9 t -80.54 -23.65 39.85 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.663 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.8 t -69.31 -28.78 66.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.572 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -99.84 135.86 20.37 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.495 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.599 ' O ' HG22 ' A' ' 11' ' ' THR . 72.6 Cg_endo -74.99 -3.02 13.31 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.328 2.019 . . . . 0.0 112.902 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.7 t -83.11 -57.73 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-O 121.349 0.595 . . . . 0.0 109.552 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.86 -36.88 82.54 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.346 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 8' ' ' PRO . 6.1 t -44.81 -40.1 5.86 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.926 0.393 . . . . 0.0 111.683 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.9 t -60.06 -52.71 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.364 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -80.07 1.08 29.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.485 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.419 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -133.83 60.01 42.94 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.809 0.337 . . . . 0.0 111.036 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 69.3 Cg_endo -89.51 33.53 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.888 2.392 . . . . 0.0 112.609 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.63 -19.96 11.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.384 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.545 HD12 ' N ' ' A' ' 18' ' ' CYS . 1.2 pp -110.53 -29.23 2.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.752 0.311 . . . . 0.0 111.057 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.545 ' N ' HD12 ' A' ' 17' ' ' ILE . 92.4 m . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.922 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.726 0.298 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -86.42 -45.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.785 2.323 . . . . 0.0 112.304 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.01 -10.42 21.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.987 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 38.0 t -77.37 -29.4 53.28 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.51 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.8 t -68.26 -26.57 65.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.539 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -99.84 116.63 64.56 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.491 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.794 ' O ' HG22 ' A' ' 11' ' ' THR . 35.8 Cg_exo -60.66 -11.56 17.83 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.452 2.102 . . . . 0.0 113.005 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.2 t -78.72 -55.07 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.278 0.561 . . . . 0.0 109.878 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.94 -34.91 78.47 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.427 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.794 HG22 ' O ' ' A' ' 8' ' ' PRO . 5.7 t -44.77 -35.72 2.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.906 0.384 . . . . 0.0 111.73 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.401 ' H ' HG23 ' A' ' 12' ' ' VAL . 7.6 t -63.34 -49.54 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.238 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -87.44 10.94 15.9 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.411 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.776 ' HB3' HD11 ' A' ' 17' ' ' ILE . 1.4 m-80 -134.09 61.92 53.88 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.777 0.322 . . . . 0.0 110.96 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -89.73 21.18 0.94 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.859 2.373 . . . . 0.0 112.7 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -103.53 -25.46 13.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.209 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.776 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.1 pp -110.92 -29.02 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.16 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.536 ' N ' HD12 ' A' ' 17' ' ' ILE . 9.7 m . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.927 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.527 0.07 0 CA-C-O 120.766 0.317 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -85.98 -44.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.689 2.259 . . . . 0.0 112.283 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.0 -7.93 26.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.073 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 46.2 t -81.19 -30.79 34.25 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.539 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.3 m -68.48 -27.81 66.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.416 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 2.7 m-80 -99.92 118.17 62.15 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.502 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.779 ' O ' HG22 ' A' ' 11' ' ' THR . 25.5 Cg_exo -62.66 -9.49 16.23 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.44 2.093 . . . . 0.0 113.035 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.6 t -80.03 -56.35 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 121.234 0.54 . . . . 0.0 109.892 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -63.55 -31.92 73.22 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.566 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.779 HG22 ' O ' ' A' ' 8' ' ' PRO . 7.0 t -44.78 -35.42 2.72 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.75 0.31 . . . . 0.0 111.634 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 12' ' ' VAL . 4.8 t -60.19 -52.12 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.035 0.445 . . . . 0.0 111.096 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -72.64 -9.17 58.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.226 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.585 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.6 OUTLIER -128.19 68.75 77.05 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-O 120.839 0.352 . . . . 0.0 110.99 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -90.7 24.99 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.828 2.352 . . . . 0.0 112.578 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -104.15 -25.7 12.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.323 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.604 HD12 ' N ' ' A' ' 18' ' ' CYS . 1.2 pp -110.23 -29.96 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.815 0.34 . . . . 0.0 111.136 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.604 ' N ' HD12 ' A' ' 17' ' ' ILE . 52.5 m . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.805 0.335 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.475 ' OD2' HG21 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -75.99 164.01 63.08 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -86.33 -45.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.779 2.32 . . . . 0.0 112.365 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.76 -8.85 23.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.09 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.07 -28.64 35.2 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.556 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -68.29 -27.3 66.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.421 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -99.85 118.0 62.51 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.416 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.717 ' O ' HG22 ' A' ' 11' ' ' THR . 26.2 Cg_exo -62.29 -9.92 16.79 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.469 2.113 . . . . 0.0 113.022 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.5 t -78.76 -55.87 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.272 0.558 . . . . 0.0 109.813 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 t -63.24 -36.63 84.28 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.432 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.717 HG22 ' O ' ' A' ' 8' ' ' PRO . 3.9 t -44.72 -37.01 3.43 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.881 0.372 . . . . 0.0 111.731 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.0 t -63.14 -52.42 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.337 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.75 -0.47 34.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.505 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.619 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -131.98 61.6 58.91 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 120.864 0.364 . . . . 0.0 111.036 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -89.11 30.33 0.42 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.912 2.408 . . . . 0.0 112.668 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -111.3 -21.13 12.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.324 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.619 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.1 pp -110.86 -28.1 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.788 0.328 . . . . 0.0 111.201 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.458 ' N ' HD12 ' A' ' 17' ' ' ILE . 80.4 m -89.78 -23.19 21.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.916 0.389 . . . . 0.0 110.937 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.359 0 O-C-N 122.043 -0.411 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.894 0.378 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.27 175.41 0.41 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.904 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -88.27 -45.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.858 2.372 . . . . 0.0 112.447 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -56.46 -17.87 9.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.8 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.732 ' HA ' HG22 ' A' ' 11' ' ' THR . 36.2 t -68.58 -24.58 64.62 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.63 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 97.3 p -69.77 -29.48 66.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.772 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.981 ' O ' HG23 ' A' ' 11' ' ' THR . 3.1 m-80 -99.95 105.02 32.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.713 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.501 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 17.9 Cg_endo -59.57 1.34 0.4 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.854 2.37 . . . . 0.0 113.873 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.7 t -80.48 -56.51 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.128 0.49 . . . . 0.0 110.249 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.6 p -79.88 -28.85 39.89 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.423 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.981 HG23 ' O ' ' A' ' 7' ' ' ASN . 65.2 p -44.59 -32.87 1.58 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.672 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.418 ' H ' HG23 ' A' ' 12' ' ' VAL . 9.4 t -54.68 -49.5 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 121.027 0.441 . . . . 0.0 111.259 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -76.95 -4.42 43.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.414 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.619 ' HB3' HD11 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -129.07 65.74 74.7 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.835 0.35 . . . . 0.0 111.021 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -89.14 22.85 0.78 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.868 2.379 . . . . 0.0 112.853 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -99.8 -20.56 16.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 0.0 110.846 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.819 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -118.77 -39.37 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 121.062 0.458 . . . . 0.0 110.729 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.403 ' N ' HG12 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -93.17 37.52 1.04 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.944 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.341 0 O-C-N 122.018 -0.426 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 10.6 mtp180 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.807 0.337 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.25 169.33 1.27 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -85.94 -44.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.779 2.32 . . . . 0.0 112.345 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -68.29 -6.86 26.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.031 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.811 ' HA ' HG22 ' A' ' 11' ' ' THR . 51.6 t -84.54 -25.38 28.8 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.502 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.5 m -68.55 -31.25 70.33 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.025 0.44 . . . . 0.0 110.296 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.901 ' O ' HG23 ' A' ' 11' ' ' THR . 16.3 m-80 -100.44 115.86 64.97 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.462 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.515 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 52.3 Cg_exo -54.7 -14.63 7.9 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.591 2.194 . . . . 0.0 113.118 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t -76.48 -56.48 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.285 0.564 . . . . 0.0 109.733 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.06 -33.06 71.44 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.936 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.901 HG23 ' O ' ' A' ' 7' ' ' ASN . 54.5 p -44.82 -41.76 7.3 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.545 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.432 ' H ' HG23 ' A' ' 12' ' ' VAL . 4.2 t -53.88 -52.1 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.251 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 20.1 m80 -66.23 -14.02 61.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.209 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.544 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -120.58 73.37 22.51 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-O 120.779 0.324 . . . . 0.0 111.037 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.559 ' HA ' ' N ' ' A' ' 19' ' ' NH2 . 64.3 Cg_endo -90.17 28.43 0.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.907 2.405 . . . . 0.0 112.726 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -99.8 -22.59 15.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.982 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.838 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.13 -40.19 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.03 0.443 . . . . 0.0 110.751 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.407 ' N ' HG12 ' A' ' 17' ' ' ILE . 26.8 p -150.01 40.51 0.8 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.824 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . 0.559 ' N ' ' HA ' ' A' ' 15' ' ' PRO . . . . . . . . 0 C--N 1.328 -0.352 0 O-C-N 122.037 -0.415 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.804 0.335 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.55 175.23 4.83 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -87.61 -44.41 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.924 2.416 . . . . 0.0 112.371 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.32 -13.0 15.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.018 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -74.56 -27.79 60.66 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.529 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.82 -24.91 64.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.551 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -99.87 119.13 60.45 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.493 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.791 ' O ' HG22 ' A' ' 11' ' ' THR . 34.3 Cg_exo -60.84 -12.42 22.0 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.457 2.105 . . . . 0.0 113.003 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 36.2 t -77.37 -53.38 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.23 0.538 . . . . 0.0 109.993 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.97 -37.14 86.31 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.489 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.791 HG22 ' O ' ' A' ' 8' ' ' PRO . 5.5 t -44.8 -35.41 2.73 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.3 t -59.86 -48.74 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 121.051 0.453 . . . . 0.0 111.298 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -89.6 15.58 9.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.375 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.462 ' HB3' HD11 ' A' ' 17' ' ' ILE . 2.0 m-80 -140.04 58.29 10.8 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.754 0.311 . . . . 0.0 110.935 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 68.9 Cg_endo -89.27 24.55 0.66 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.799 2.333 . . . . 0.0 112.843 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -99.74 -21.91 15.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.864 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.818 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -117.4 -39.6 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.706 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.41 ' N ' HG12 ' A' ' 17' ' ' ILE . 2.1 m -103.66 143.25 33.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.904 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.376 0 O-C-N 122.07 -0.393 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.86 0.362 . . . . 0.0 111.172 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.37 161.66 13.12 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -87.81 -44.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.88 2.387 . . . . 0.0 112.324 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.5 m -63.89 -10.11 19.01 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.213 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.22 -30.78 43.42 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.671 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.7 t -68.14 -28.29 67.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.549 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -99.86 127.69 33.06 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.414 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.604 ' O ' HG22 ' A' ' 11' ' ' THR . 59.0 Cg_endo -71.82 -5.8 17.82 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.31 2.007 . . . . 0.0 112.81 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.8 t -82.09 -57.44 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.298 0.57 . . . . 0.0 109.539 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 t -63.82 -35.5 80.81 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.54 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.604 HG22 ' O ' ' A' ' 8' ' ' PRO . 5.3 t -44.8 -39.07 4.97 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.94 0.4 . . . . 0.0 111.638 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 t -60.63 -52.1 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.382 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -79.34 0.52 28.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.469 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.804 ' HB3' HD11 ' A' ' 17' ' ' ILE . 2.6 m-80 -127.7 67.27 72.54 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.786 0.327 . . . . 0.0 110.934 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -89.43 19.18 1.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.804 2.336 . . . . 0.0 112.654 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -99.99 -28.94 12.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.131 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.804 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.1 pp -110.83 -29.13 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.106 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.562 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -98.34 161.77 13.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.856 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.319 0 O-C-N 122.077 -0.389 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.856 0.36 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.99 162.22 73.59 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -86.78 -44.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.82 2.347 . . . . 0.0 112.392 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -67.37 -7.51 25.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.196 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -82.07 -35.6 28.51 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.385 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.7 t -70.06 -23.4 63.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.651 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.81 114.02 65.42 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.446 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.675 ' O ' HG22 ' A' ' 11' ' ' THR . 38.7 Cg_exo -60.27 -12.48 20.14 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.48 2.12 . . . . 0.0 112.989 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.82 -55.13 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.3 0.571 . . . . 0.0 109.763 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.37 -36.75 84.95 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.508 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 8' ' ' PRO . 2.8 t -44.87 -36.72 3.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.96 0.409 . . . . 0.0 111.627 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -61.83 -50.91 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.396 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -82.6 4.86 22.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.457 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.812 ' HB3' HD11 ' A' ' 17' ' ' ILE . 1.2 m-80 -129.54 68.17 80.01 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.837 0.351 . . . . 0.0 110.906 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -90.06 19.93 1.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.874 2.383 . . . . 0.0 112.707 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -99.88 -30.38 12.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.812 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.2 pp -111.47 -29.67 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.04 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.707 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -108.07 -97.39 0.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.842 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.343 0 O-C-N 122.009 -0.432 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 6.2 mtt85 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.808 0.337 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.97 149.73 96.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -88.06 -45.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.855 2.37 . . . . 0.0 112.584 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 10' ' ' CYS . 1.1 m -63.75 -9.99 17.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.318 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.871 ' HA ' HG22 ' A' ' 11' ' ' THR . 3.9 t -82.66 -25.68 32.86 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-O 120.831 0.348 . . . . 0.0 110.551 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.0 m -67.55 -31.34 71.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.028 0.442 . . . . 0.0 110.108 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.96 ' O ' HG23 ' A' ' 11' ' ' THR . 1.2 t-20 -99.94 117.26 63.7 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.231 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.52 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 19.6 Cg_endo -58.38 -11.47 11.0 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.54 2.16 . . . . 0.0 113.044 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.75 -56.09 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.262 0.553 . . . . 0.0 109.628 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 4' ' ' CYS . 0.8 OUTLIER -69.44 -36.4 76.61 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.899 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.96 HG23 ' O ' ' A' ' 7' ' ' ASN . 80.4 p -44.71 -37.29 3.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.563 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 12' ' ' VAL . 8.4 t -58.11 -49.26 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.351 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -80.32 2.79 23.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.616 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -131.31 60.52 53.25 Favored Pre-proline 0 CA--C 1.529 0.164 0 CA-C-O 120.886 0.374 . . . . 0.0 110.961 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -87.89 29.63 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.912 2.408 . . . . 0.0 112.86 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.91 -23.11 15.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.322 . . . . 0.0 110.939 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.821 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -117.1 -39.92 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.016 0.436 . . . . 0.0 110.727 179.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.411 ' N ' HG12 ' A' ' 17' ' ' ILE . 9.7 m -73.23 140.59 47.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.896 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.35 0 O-C-N 122.059 -0.401 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 77.6 mtt-85 . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.802 0.334 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.03 167.96 2.47 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.82 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -87.25 -44.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.809 2.339 . . . . 0.0 112.33 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.65 -12.86 17.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.943 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.927 ' HA ' HG22 ' A' ' 11' ' ' THR . 1.2 m -76.58 -23.94 53.52 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.659 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.9 t -67.34 -29.86 69.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.005 0.431 . . . . 0.0 110.331 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.911 ' O ' HG23 ' A' ' 11' ' ' THR . 0.5 OUTLIER -101.86 111.8 64.54 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.468 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.598 ' O ' HG23 ' A' ' 12' ' ' VAL . 50.9 Cg_exo -54.17 -14.52 6.47 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.552 2.168 . . . . 0.0 113.111 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.1 t -73.72 -55.62 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-O 121.336 0.589 . . . . 0.0 109.496 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.8 t -67.24 -40.85 86.36 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.457 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.927 HG22 ' HA ' ' A' ' 5' ' ' CYS . 47.3 p -44.93 -41.45 7.24 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.597 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 8' ' ' PRO . 6.6 t -52.83 -49.67 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.455 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.22 16.05 7.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.5 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.456 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 4.1 m-80 -137.27 58.13 16.65 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.767 0.318 . . . . 0.0 110.985 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.456 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 67.9 Cg_endo -89.43 28.27 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.838 2.358 . . . . 0.0 112.812 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.81 -22.82 15.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.874 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.834 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.94 -39.99 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-O 121.011 0.434 . . . . 0.0 110.707 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.407 ' N ' HG12 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -72.05 107.6 4.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.832 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.349 0 O-C-N 122.066 -0.396 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.6 mpp_? . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.817 0.342 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.8 166.31 3.61 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.878 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -85.67 -46.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.703 2.269 . . . . 0.0 112.332 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.597 ' O ' ' HB3' ' A' ' 10' ' ' CYS . 1.1 m -65.28 -9.45 24.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.912 178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.2 t -84.11 -28.07 27.76 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.839 0.352 . . . . 0.0 110.715 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -73.37 -28.13 61.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.962 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -99.85 119.41 59.76 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.636 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.859 ' O ' HG22 ' A' ' 11' ' ' THR . 48.9 Cg_exo -55.77 -26.18 55.39 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.389 2.059 . . . . 0.0 112.604 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.528 HG13 ' N ' ' A' ' 10' ' ' CYS . 9.0 p -68.94 -48.23 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 121.587 0.708 . . . . 0.0 109.925 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.597 ' HB3' ' O ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER -61.26 -48.04 83.25 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.436 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.859 HG22 ' O ' ' A' ' 8' ' ' PRO . 4.0 t -44.47 -32.13 1.3 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.859 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.5 t -62.87 -52.51 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 120.95 0.405 . . . . 0.0 111.395 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -94.31 13.68 22.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.431 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.434 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 1.1 m-80 -140.13 58.04 10.19 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.799 0.333 . . . . 0.0 111.055 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.434 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 67.3 Cg_endo -88.23 22.27 0.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.743 2.296 . . . . 0.0 112.94 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -99.74 -21.3 15.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.802 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.807 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -117.95 -39.45 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.675 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 t -97.2 -163.67 1.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.89 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.348 0 O-C-N 122.077 -0.389 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.78 0.324 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.82 172.05 1.25 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.845 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -86.74 -45.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.837 2.358 . . . . 0.0 112.408 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.1 m -64.45 -9.81 20.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.1 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.623 ' SG ' HD13 ' A' ' 17' ' ' ILE . 57.7 m -78.6 -30.4 46.59 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.433 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -68.08 -26.63 65.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.413 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -99.88 115.46 65.54 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.386 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.685 ' O ' HG22 ' A' ' 11' ' ' THR . 39.4 Cg_exo -60.32 -11.67 17.23 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.394 2.063 . . . . 0.0 113.02 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.4 t -77.68 -55.26 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.244 0.545 . . . . 0.0 109.682 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.19 -38.98 93.3 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.39 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.685 HG22 ' O ' ' A' ' 8' ' ' PRO . 2.5 t -44.95 -36.79 3.55 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.873 0.368 . . . . 0.0 111.528 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.7 t -61.62 -49.87 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.34 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -87.35 11.24 14.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.499 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.797 ' HB3' HD11 ' A' ' 17' ' ' ILE . 1.6 m-80 -132.36 65.4 74.79 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-O 120.861 0.362 . . . . 0.0 110.953 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -90.87 20.48 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.861 2.374 . . . . 0.0 112.592 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -101.03 -28.18 12.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.188 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.797 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.1 pp -110.21 -29.52 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.121 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.641 ' H ' HD12 ' A' ' 17' ' ' ILE . 20.9 p -164.44 -50.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 110.979 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . 0.444 ' N ' ' O ' ' A' ' 14' ' ' ASN . . . . . . . . 0 C--N 1.327 -0.379 0 O-C-N 122.083 -0.386 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.766 0.317 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.91 149.38 53.3 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -87.77 -44.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.868 2.379 . . . . 0.0 112.298 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.1 t -62.51 -11.36 15.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.127 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.91 -27.27 28.7 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.613 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.2 m -72.8 -22.64 60.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -99.83 107.34 45.87 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.698 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.743 ' O ' HG22 ' A' ' 11' ' ' THR . 52.2 Cg_exo -54.87 -21.68 27.09 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.412 2.075 . . . . 0.0 112.543 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.8 t -74.96 -52.18 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-O 121.452 0.644 . . . . 0.0 109.389 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.9 t -63.44 -41.57 98.67 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.282 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.743 HG22 ' O ' ' A' ' 8' ' ' PRO . 1.6 t -45.35 -36.58 4.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.849 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 t -58.82 -55.43 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.375 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -66.53 -15.4 63.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.214 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.778 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -122.64 76.5 46.65 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.208 -179.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -91.16 26.93 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.964 2.443 . . . . 0.0 112.624 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -106.34 -27.78 10.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.242 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.778 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.0 OUTLIER -108.91 -28.0 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.196 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.504 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.6 OUTLIER -107.11 -77.93 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.867 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.34 0 O-C-N 122.024 -0.422 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.871 0.367 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.85 174.16 0.48 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -86.5 -44.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.793 2.328 . . . . 0.0 112.319 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -66.1 -8.81 25.88 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.143 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.92 -24.82 32.9 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.598 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.61 -31.57 71.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.983 0.421 . . . . 0.0 110.26 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -99.97 134.91 20.6 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.379 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.684 ' O ' HG22 ' A' ' 11' ' ' THR . 74.0 Cg_endo -75.63 -1.92 11.95 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.341 2.027 . . . . 0.0 112.914 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t -84.78 -58.99 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.222 0.534 . . . . 0.0 109.693 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -61.51 -30.83 70.87 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.496 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.684 HG22 ' O ' ' A' ' 8' ' ' PRO . 14.6 t -44.75 -39.19 4.99 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.855 0.359 . . . . 0.0 111.743 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 t -59.8 -50.61 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.188 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.6 -3.19 39.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.46 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.416 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -131.94 59.49 44.88 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-O 120.82 0.343 . . . . 0.0 111.08 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.416 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 65.7 Cg_endo -88.65 27.91 0.5 Allowed 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.817 2.344 . . . . 0.0 112.812 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -99.84 -23.11 15.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 110.878 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.821 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.71 -39.83 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.696 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.413 ' N ' HG12 ' A' ' 17' ' ' ILE . 12.4 m -80.87 79.43 7.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.889 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.372 0 O-C-N 122.103 -0.373 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.835 0.35 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -59.89 158.35 25.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -86.95 -46.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.818 2.345 . . . . 0.0 112.483 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.584 ' O ' ' HB3' ' A' ' 10' ' ' CYS . 1.2 m -64.12 -9.82 18.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.12 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.1 m -83.26 -25.72 31.38 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.791 0.329 . . . . 0.0 110.838 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -31.03 66.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.82 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -99.87 138.6 20.38 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.694 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.829 ' O ' HG22 ' A' ' 11' ' ' THR . 59.1 Cg_endo -71.97 -22.77 22.68 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.359 2.039 . . . . 0.0 112.476 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.2 t -73.17 -50.71 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.584 ' HB3' ' O ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -57.29 -47.21 82.07 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.334 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.829 HG22 ' O ' ' A' ' 8' ' ' PRO . 4.9 t -44.68 -33.71 1.94 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.83 -178.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 t -66.96 -55.95 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.135 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -71.25 -9.84 58.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.251 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.803 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -124.58 71.7 58.7 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-O 120.812 0.339 . . . . 0.0 111.037 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -90.98 18.78 1.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.84 2.36 . . . . 0.0 112.566 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -99.98 -28.33 13.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.199 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.803 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.2 pp -110.32 -29.34 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.092 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.619 ' H ' HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -104.63 151.05 24.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.854 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.353 0 O-C-N 122.083 -0.385 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.817 0.341 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -77.84 146.43 72.27 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.857 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -86.1 -46.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.662 2.241 . . . . 0.0 112.556 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.2 m -67.52 -7.27 24.53 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.194 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.9 t -85.27 -28.91 25.01 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.764 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.4 m -69.0 -30.83 69.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.531 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -99.94 133.23 21.79 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.47 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.582 ' O ' HG22 ' A' ' 11' ' ' THR . 74.0 Cg_endo -75.52 -1.78 11.76 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.358 2.039 . . . . 0.0 112.926 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t -84.18 -58.57 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 121.264 0.554 . . . . 0.0 109.671 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 t -64.29 -33.16 75.18 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.444 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.582 HG22 ' O ' ' A' ' 8' ' ' PRO . 6.5 t -44.68 -39.94 5.52 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.961 0.41 . . . . 0.0 111.728 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.4 ' H ' HG23 ' A' ' 12' ' ' VAL . 3.4 t -60.26 -53.37 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.511 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -84.68 5.59 27.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.698 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.555 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -135.68 54.61 10.62 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.737 0.303 . . . . 0.0 111.181 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 61.1 Cg_endo -89.31 21.46 0.94 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.844 2.363 . . . . 0.0 112.74 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -107.49 -9.16 16.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.699 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.555 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.1 pp -112.33 -28.89 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.771 0.319 . . . . 0.0 111.216 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.471 ' N ' HD12 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -127.38 -48.67 1.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.876 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 O-C-N 122.047 -0.408 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.804 0.335 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.588 ' OD1' HG21 ' A' ' 17' ' ' ILE . 0.4 OUTLIER -72.01 152.48 92.85 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.941 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -87.01 -44.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.866 2.377 . . . . 0.0 112.379 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 m -66.84 -7.74 23.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.272 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.504 ' HB2' HD13 ' A' ' 17' ' ' ILE . 49.1 t -84.96 -26.21 27.31 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.636 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.9 -31.5 70.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.372 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -99.89 134.94 20.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.433 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.646 ' O ' HG22 ' A' ' 11' ' ' THR . 73.5 Cg_endo -76.01 -1.46 11.44 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.321 2.014 . . . . 0.0 112.869 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.5 t -84.91 -59.03 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 121.248 0.547 . . . . 0.0 109.719 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -62.99 -30.29 71.48 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.534 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 8' ' ' PRO . 14.6 t -44.84 -39.79 5.64 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.825 0.345 . . . . 0.0 111.759 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.406 ' H ' HG23 ' A' ' 12' ' ' VAL . 7.1 t -57.67 -50.45 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.279 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -78.51 -3.26 42.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.347 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.407 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -132.18 60.62 52.34 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-O 120.8 0.333 . . . . 0.0 110.965 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -87.89 38.58 0.5 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.853 2.369 . . . . 0.0 112.646 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -116.28 -18.06 10.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.404 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.588 HG21 ' OD1' ' A' ' 2' ' ' ASP . 1.0 OUTLIER -110.86 -27.55 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.729 0.299 . . . . 0.0 111.191 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.437 ' H ' HD12 ' A' ' 17' ' ' ILE . 29.8 p -169.33 14.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.895 0.378 . . . . 0.0 110.912 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.352 0 O-C-N 122.077 -0.389 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.776 0.322 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.404 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.2 OUTLIER -84.92 175.97 4.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 2' ' ' ASP . 87.8 Cg_endo -86.41 -45.43 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.824 2.35 . . . . 0.0 112.371 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.15 -10.19 21.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.07 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 52.3 t -79.21 -27.17 42.51 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.579 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.97 -28.27 67.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.412 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -99.82 130.39 26.57 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.452 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.788 ' O ' HG22 ' A' ' 11' ' ' THR . 56.5 Cg_endo -70.54 -13.03 32.34 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.367 2.045 . . . . 0.0 112.811 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.542 HG13 ' N ' ' A' ' 10' ' ' CYS . 9.8 p -76.54 -50.13 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 121.293 0.568 . . . . 0.0 110.887 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.542 ' N ' HG13 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -69.63 -34.75 74.49 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.627 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.788 HG22 ' O ' ' A' ' 8' ' ' PRO . 6.3 t -44.64 -34.61 2.26 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.805 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 t -60.52 -52.09 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.301 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.3 -5.15 57.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.399 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.526 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -132.69 62.06 60.35 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 120.831 0.348 . . . . 0.0 110.866 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -90.33 21.0 0.92 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.82 2.347 . . . . 0.0 112.879 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -99.85 -19.33 16.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.009 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.812 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.18 -39.81 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 121.032 0.444 . . . . 0.0 110.608 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.416 ' N ' HG12 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -85.53 -30.98 22.97 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.981 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.343 0 O-C-N 122.04 -0.412 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.6 ptt85 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.866 0.365 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.501 ' OD2' HG21 ' A' ' 17' ' ' ILE . 3.6 m-20 -82.77 162.05 56.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.804 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -88.08 -45.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.826 2.351 . . . . 0.0 112.549 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.88 -10.62 13.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.253 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -30.51 46.2 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.89 0.376 . . . . 0.0 110.573 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 t -70.83 -23.29 62.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.812 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -99.84 116.47 64.69 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.482 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.672 ' O ' HG22 ' A' ' 11' ' ' THR . 34.8 Cg_exo -60.76 -12.61 22.46 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.456 2.104 . . . . 0.0 112.954 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.5 t -77.48 -54.67 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 121.305 0.574 . . . . 0.0 109.765 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.74 -37.87 89.07 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.494 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.672 HG22 ' O ' ' A' ' 8' ' ' PRO . 2.5 t -44.87 -37.05 3.62 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.837 0.351 . . . . 0.0 111.752 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.0 t -59.24 -50.37 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.339 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -95.55 21.31 8.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.357 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.567 ' HB3' HD11 ' A' ' 17' ' ' ILE . 3.0 m-80 -136.63 55.73 11.74 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.707 0.289 . . . . 0.0 111.153 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 64.1 Cg_endo -90.16 20.32 1.04 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.8 2.333 . . . . 0.0 112.787 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -99.83 -20.13 16.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.9 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.805 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -116.62 -39.52 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.038 0.447 . . . . 0.0 110.611 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.5 m -78.12 77.98 4.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.863 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.344 0 O-C-N 122.046 -0.408 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.6 mtp-105 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.831 0.348 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.93 168.04 5.18 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.855 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -86.55 -45.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.809 2.339 . . . . 0.0 112.333 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.69 -10.9 21.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.088 178.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.9 t -80.54 -23.65 39.85 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.663 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.8 t -69.31 -28.78 66.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.572 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -99.84 135.86 20.37 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.495 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.599 ' O ' HG22 ' A' ' 11' ' ' THR . 72.6 Cg_endo -74.99 -3.02 13.31 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.328 2.019 . . . . 0.0 112.902 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.7 t -83.11 -57.73 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-O 121.349 0.595 . . . . 0.0 109.552 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.86 -36.88 82.54 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.346 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 8' ' ' PRO . 6.1 t -44.81 -40.1 5.86 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.926 0.393 . . . . 0.0 111.683 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.9 t -60.06 -52.71 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.364 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -80.07 1.08 29.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.485 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.419 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -133.83 60.01 42.94 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.809 0.337 . . . . 0.0 111.036 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 14' ' ' ASN . 69.3 Cg_endo -89.51 33.53 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.888 2.392 . . . . 0.0 112.609 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.63 -19.96 11.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.384 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.545 HD12 ' N ' ' A' ' 18' ' ' CYS . 1.2 pp -110.53 -29.23 2.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.752 0.311 . . . . 0.0 111.057 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.545 ' N ' HD12 ' A' ' 17' ' ' ILE . 92.4 m -133.8 105.35 6.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.922 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 O-C-N 122.066 -0.396 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.814 0.34 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.26 171.96 11.1 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.808 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -86.42 -45.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.785 2.323 . . . . 0.0 112.304 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.01 -10.42 21.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.987 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 38.0 t -77.37 -29.4 53.28 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.51 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.8 t -68.26 -26.57 65.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.539 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -99.84 116.63 64.56 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.491 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.794 ' O ' HG22 ' A' ' 11' ' ' THR . 35.8 Cg_exo -60.66 -11.56 17.83 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.452 2.102 . . . . 0.0 113.005 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.2 t -78.72 -55.07 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.278 0.561 . . . . 0.0 109.878 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.94 -34.91 78.47 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.427 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.794 HG22 ' O ' ' A' ' 8' ' ' PRO . 5.7 t -44.77 -35.72 2.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.906 0.384 . . . . 0.0 111.73 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.401 ' H ' HG23 ' A' ' 12' ' ' VAL . 7.6 t -63.34 -49.54 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.238 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -87.44 10.94 15.9 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.411 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.776 ' HB3' HD11 ' A' ' 17' ' ' ILE . 1.4 m-80 -134.09 61.92 53.88 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.777 0.322 . . . . 0.0 110.96 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -89.73 21.18 0.94 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.859 2.373 . . . . 0.0 112.7 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -103.53 -25.46 13.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.209 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.776 HD11 ' HB3' ' A' ' 14' ' ' ASN . 1.1 pp -110.92 -29.02 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.16 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.536 ' N ' HD12 ' A' ' 17' ' ' ILE . 9.7 m -138.41 -166.38 1.98 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.927 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.357 0 O-C-N 122.079 -0.388 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.828 0.347 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.92 162.81 8.81 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.813 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -85.98 -44.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.689 2.259 . . . . 0.0 112.283 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.0 -7.93 26.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.073 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 46.2 t -81.19 -30.79 34.25 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.539 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.3 m -68.48 -27.81 66.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.416 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 2.7 m-80 -99.92 118.17 62.15 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.502 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.779 ' O ' HG22 ' A' ' 11' ' ' THR . 25.5 Cg_exo -62.66 -9.49 16.23 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.44 2.093 . . . . 0.0 113.035 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.6 t -80.03 -56.35 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 121.234 0.54 . . . . 0.0 109.892 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -63.55 -31.92 73.22 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.566 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.779 HG22 ' O ' ' A' ' 8' ' ' PRO . 7.0 t -44.78 -35.42 2.72 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.75 0.31 . . . . 0.0 111.634 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 12' ' ' VAL . 4.8 t -60.19 -52.12 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.035 0.445 . . . . 0.0 111.096 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -72.64 -9.17 58.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.226 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.585 ' HB3' HD11 ' A' ' 17' ' ' ILE . 0.6 OUTLIER -128.19 68.75 77.05 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-O 120.839 0.352 . . . . 0.0 110.99 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -90.7 24.99 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.828 2.352 . . . . 0.0 112.578 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -104.15 -25.7 12.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.323 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.604 HD12 ' N ' ' A' ' 18' ' ' CYS . 1.2 pp -110.23 -29.96 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.815 0.34 . . . . 0.0 111.136 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.604 ' N ' HD12 ' A' ' 17' ' ' ILE . 52.5 m -147.08 166.08 27.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.391 0 O-C-N 122.065 -0.397 . . . . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_